NURSING RNSG 25392539 Exam 2 Blue Print Edwardo Mata
1. Metabolism/Liver Failure/Nutrition
Improving Nutritional Status
• The patient with cirrhosis without ascites, edema, or signs of impending hepatic coma should re
...
NURSING RNSG 25392539 Exam 2 Blue Print Edwardo Mata
1. Metabolism/Liver Failure/Nutrition
Improving Nutritional Status
• The patient with cirrhosis without ascites, edema, or signs of impending hepatic coma should receive a nutritious, high protein diet, if tolerated, supplemented by vitamins of the B complex, as well as A, C, and K. The nurse encourages the patient to eat. If ascites is present, small, frequent meals may be better tolerated than three large meals because of the abdominal pressure exerted by ascites.
• Imbalance of the intestinal flora is not uncommon. Research suggests that the oral ingestion of 1 cup of probiotic yogurt three times a day reduces intestinal flora imbalance by decreasing Escherichia coli counts.
• Patients with fatty stools (steatorrhea) should receive water-soluble forms of fat-soluble vitamins A, D, and E (Aquasol A, D, and E). Folic acid and iron are prescribed to prevent anemia. If the patient shows signs of impending or advancing coma despite medical interventions, the amount of protein in the diet may be decreased temporarily.
o Protein is restricted if encephalopathy develops that cannot be effectively managed with lactulose and other medical treatment strategies. Incorporating vegetable protein to meet protein needs may decrease the risk for encephalopathy.
o Sodium restriction is also indicated to prevent ascites. Patients with prolonged or severe anorexia and those who are vomiting or eating poorly for any reason may receive nutrients by the enteral or parenteral route.
(Hinkle 1376)
A nurse is caring for a patient with liver failure and is performing an assessment in theknowledge of the patient's increased risk of bleeding. The nurse recognizes that this riskis related to the patient's inability to synthesize prothrombin in the liver. What factor most likely contributes to this loss of function?
A)Alterations in glucose metabolism
B)Retention of bile salts
C)Inadequate production of albumin by hepatocytes
D)Inability of the liver to use vitamin K
Ans:D
Feedback:Decreased production of several clotting factors may be partially due to deficientabsorption of vitamin K from the GI tract. This probably is caused by the inability ofliver cells to use vitamin K to make prothrombin
A nurse is performing an admission assessment of a patient with a diagnosis ofcirrhosis. What technique should the nurse use to palpate the patient's liver?
A)Place hand under the right lower abdominal
quadrant and press down lightly with the other hand.
B)Place the left hand over the abdomen and behind the left side at the 11th rib.
C)Place hand under right lower rib cage and press down lightly with the other hand.
D)Hold hand 90 degrees to right side of the abdomen and push down firmly.
Ans:C
Feedback:To palpate the liver, the examiner places one hand under the right lower rib cage andpresses downward with light pressure with the other hand
A nurse is caring for a patient with hepatic encephalopathy. While making the initialshift assessment, the nurse notes that the patient has a flapping tremor of the hands. The nurse should document the presence of what sign of liver disease?
A)Asterixis
B)Constructional apraxia
C)Fetor hepaticus
D)Palmar erythema
Ans:A
Feedback:The nurse will document that a patient exhibiting a flapping tremor of the hands isdemonstrating asterixis.
A local public health nurse is informed that a cook in a local restaurant has beendiagnosed with hepatitis A. What should the nurse advise individuals to obtain who ateat this restaurant and have never received the hepatitis A vaccine?
A)The hepatitis A vaccine
B)Albumin infusion
C)The hepatitis A and B vaccines
D)An immune globulin injection
Ans:D
Feedback:For people who have not been previously vaccinated, hepatitis A can be prevented bythe intramuscular administration of immune globulin during the incubation period, ifgiven within 2 weeks of exposure. Administration of the hepatitis A vaccine will notprotect the patient exposed to hepatitis A, as protection will take a few weeks todevelop after the first dose of the vaccine. The hepatitis B vaccine provides protectionagain the hepatitis B virus, but plays no role in protection for the patient exposed tohepatitis A. Albumin confers no therapeutic benefit.
A participant in a health fair has asked the nurse about the role of drugs in liver disease.What health promotion teaching has the most potential to prevent drug-induced hepatitis?
A)Finish all prescribed courses of antibiotics, regardless of symptom resolution.
B)Adhere to dosing recommendations of OTC analgesics.
C)Ensure that expired medications are disposed of safely.
D)Ensure that pharmacists regularly review drug regimens for potential interactions.
Ans:B
Feedback:Although any medication can affect liver function, use of acetaminophen (found inmany over-the-counter medications used to treat fever and pain) has been identified asthe leading cause of acute liver failure.
A patient has developed hepatic encephalopathy secondary to cirrhosis and is receivingcare on the medical unit. The patient's current medication regimen includes lactulose(Cephulac) four times daily. What desired outcome should the nurse relate to thispharmacologic intervention?
A)Two to 3 soft bowel movements daily
B)Significant increase in appetite and food intake
C)Absence of nausea and vomiting
D)Absence of blood or mucus in stool
Ans:A
Feedback:Lactulose (Cephulac) is administered to reduce serum ammonia levels. Two or threesoft stools per day are desirable; this indicates that lactulose is performing as intended.
A patient with liver disease has developed jaundice; the nurse is collaborating with thepatient to develop a nutritional plan. The nurse should prioritize which of the followingin the patient's plan?
A)Increased potassium intake
B)Fluid restriction to 2 L per day
C)Reduction in sodium intake
D)High-protein, low-fat diet
Ans:C
Feedback:Patients with ascites require a sharp reduction in sodium intake. Potassium intakeshould not be correspondingly increased.
A nurse is amending a patient's plan of care in light ofthe fact that the patient has recently developed ascites. What should the nurse include in this patient's care plan?
A)Mobilization with assistance at least 4 times daily
B)Administration of beta-adrenergic blockers as ordered
C)Vitamin B12 injections as ordered
D) Administration of diuretics as ordered
Ans:D
Feedback:Use of diuretics along with sodium restriction is successful in 90% of patients withascites.
A patient with a diagnosis of esophageal varices has undergone endoscopy to gauge theprogression of this complication of liver disease. Following the completion of thisdiagnostic test, what nursing intervention should the nurse perform?
A)Keep patient NPO until the results of test are known.
B)Keep patient NPO until the patient's gag reflex returns.
C)Administer analgesia until post-procedure tenderness is relieved.
D)Give the patient a cold beverage to promote swallowing ability.
Ans:B
Feedback:After the examination, fluids are not given until the patient's gag reflex returns.
A patient with end-stage liver disease has developed hypervolemia. What nursinginterventions would be most appropriate when addressing the patient's fluid volumeexcess? Select all that apply.
A)Administering diuretics
B)Administering calcium channel blockers
C)Implementing fluid restrictions
D)Implementing a 1500 kcal/day restriction
E)Enhancing patient positioning
Ans:
A, C, E
2) Metabolism/ Pancreatitis/Diagnostic Findings
CHART 50-3Criteria for Predicting Severity of Pancreatitis*
Criteria on Admission to Hospital
Age >55 years
White blood cells (WBCs) >16,000 mm3
Serum glucose >200 mg/dL (>11.1 mmol/L)
Serum lactose dehydrogenase (LDH) >350 IU/L (>350 U/L)
AST >250 IU/L
Criteria Within 48 Hours of Hospital Admission
Fall in hematocrit >10% (>0.10)
Blood urea nitrogen (BUN) increase >5 mg/dL (>1.7 morning mmol/L)
Serum calcium <8 mg/dL (<2 mmol/L)
Base deficit >4 mEq/L (>4 mmol/L)
Fluid retention or sequestration >6 L
Partial pressure of oxygen (PO2) <60 mm Hg
(Hinkle 1402) Brunner 13th Edition
Assessment and Diagnostic Findings
• The diagnosis of acute pancreatitis is based on a history of abdominal pain, the presence of known risk factors, physical examination findings, and diagnostic findings. Serum amylase and lipase levels are used in making the diagnosis of acute pancreatitis, although their elevation can be attributed to many other causes. In most cases, serum amylase and lipase levels are elevated within 24 hours of the onset of the symptoms.
• Serum amylase usually returns to normal within 48 to 72 hours, but serum lipase levels may remain elevated for a longer period, often days longer than amylase. Urinary amylase levels also become elevated and remain elevated longer than serum amylase levels. The white blood cell count is usually elevated; hypocalcemia is present in many patients and correlates well with the severity of pancreatitis. Transient hyperglycemia and glucosuria and elevated serum bilirubin levels occur in some patients with acute pancreatitis.
• X-ray studies of the abdomen and chest may be obtained to differentiate pancreatitis from other disorders that can cause similar symptoms and to detect pleural effusions. Ultrasound studies, contrast-enhanced CT scans, and magnetic resonance imaging (MRI) scans are used to identify an increase in the diameter of the pancreas and to detect pancreatic cysts, abscesses, or pseudocysts.
• Hematocrit and hemoglobin levels are used to monitor the patient for bleeding. Peritoneal fluid, obtained through paracentesis or peritoneal lavage, may contain increased levels of pancreatic enzymes.
• ERCP is rarely used in the diagnostic evaluation of acute pancreatitis, because the patient is acutely ill; however, it may be valuable in the treatment of gallstone pancreatitis.
(Hinkle 1402-1403) Brunner 13 edition
Assessment and Diagnostic Findings
• ERCP is the most useful study in the diagnosis of chronic pancreatitis. It provides details about the anatomy of the pancreas and the pancreatic and biliary ducts. It is also helpful in obtaining tissue for analysis and differentiating pancreatitis from other conditions, such as carcinoma.
Various imaging procedures, including MRI, CT scans, and ultrasound, are used in the diagnostic evaluation of patients with suspected pancreatic disorders. A CT scan or ultrasound study is also helpful to detect pancreatic cysts.
• A glucose tolerance test evaluates pancreatic islet cell function and provides necessary information for making decisions about surgical resection of the pancreas. An abnormal glucose tolerance test may indicate the presence of diabetes associated with pancreatitis.
Acute exacerbations of chronic pancreatitis may result in increased serum amylase levels. Steatorrhea is best confirmed by laboratory analysis of fecal fat content.
(Hinkle 1408) Brunner 13th edition
A patient is being treated on the acute medical unit for acute pancreatitis. The nurse hasidentified a diagnosis of Ineffective Breathing Pattern Related to Pain. Whatintervention should the nurse perform in order to address this diagnosis?
A)Position the patient supine to facilitate diaphragm movement.
B)Administer corticosteroids by nebulizer as ordered.
C)Perform oral suctioning as needed to remove secretions.
D)Maintain the patient in a semi-Fowler's position whenever possible.
Ans:D
Feedback:The nurse maintains the patient in a semi-Fowler's position to decrease pressure on thediaphragm by a distended abdomen and to increase respiratory expansion.
A community health nurse is caring for a patient whose multiple health problemsinclude chronic pancreatitis. During the most recent visit, the nurse notes that thepatient is experiencing severe abdominal pain and has vomited 3 times in the pastseveral hours. What is the nurse's most appropriate action?
A)Administer a PRN dose of pancreatic enzymes as ordered.
B)Teach the patient about the importance of abstaining from alcohol.
C)Arrange for the patient to be transported to the hospital.
D)Insert an NG tube, if available, and stay with the patient.
Ans:C
Feedback:Chronic pancreatitis is characterized by recurring attacks of severe upper abdominaland back pain, accompanied by vomiting.
A student nurse is caring for a patient who has a diagnosis of acute pancreatitis andwho is receiving parenteral nutrition. The student should prioritize which of the following assessments?
A)Fluid output
B)Oral intake
C)Blood glucose levels
D)BUN and creatinine levels
Ans:C
Feedback:In addition to administering enteral or parenteral nutrition, the nurse monitors serumglucose levels every 4 to 6 hours.
**A patient has a recent diagnosis of chronic pancreatitis and is undergoing diagnostictesting to determine pancreatic islet cell function. The nurse should anticipate whatdiagnostic test?
A)Glucose tolerance test
B)ERCP
C)Pancreatic biopsy
D)Abdominal ultrasonography
Ans:A
Feedback:A glucose tolerance test evaluates pancreatic islet cell function and provides necessaryinformation for making decisions about surgical resection of the pancreas.
A patient has just been diagnosed with chronic pancreatitis. The patient is underweightand in severe pain and diagnostic testing indicates that over 80% of the patient'spancreas has been destroyed. The patient asks the nurse why the diagnosis was notmade earlier in the disease process. What would be the nurse's best response?
A)“The symptoms of pancreatitis mimic those of much less serious illnesses.”
B)
“Your body doesn't require pancreatic function until it is under great stress, so it
is easy to go unnoticed.”
C)“Chronic pancreatitis often goes undetected until a large majority of pancreatic
function is lost.”
D)“It's likely that your other organs were compensating for your decreased pancreatic function.”
Ans:C
A patient is admitted to the ICU with acute pancreatitis. The patient's family asks whatcauses acute pancreatitis. The critical care nurse knows that a majority of patients withacute pancreatitis have what?
A)Type 1 diabetes
B)An impaired immune system
C)Undiagnosed chronic pancreatitis
D)An amylase deficiency
Ans:C
3) Metabolism/Pancreatitis/Causes
Acute Pancreatitis Causes
Gallstones enter the common bile duct and lodge at the ampulla of Vater, obstructing the flow of pancreatic juice or causing a reflux of bile from the common bile duct into the pancreatic duct, thus activating the powerful enzymes within the pancreas.
Other less common causes of pancreatitis include bacterial or viral infection, with pancreatitis occasionally developing as a complication of mumps viral infection. Spasm and edema of the ampulla of Vater, caused by duodenitis, can probably produce pancreatitis. Blunt abdominal trauma, peptic ulcer disease, ischemic vascular disease, hyperlipidemia, hypercalcemia, and the use of corticosteroids, thiazide diuretics, oral contraceptives, and other medications have also been associated with an increased incidence of pancreatitis.
(Hinkle 1402) Brunner 13th edition
In addition, there is a small incidence of hereditary pancreatitis.
(Hinkle 1402)
Chronic Pancreatitis Causes
Alcohol consumption in Western societies and malnutrition worldwide are the major causes of chronic pancreatitis.
Smoking is another factor in the development of chronic pancreatitis. Because they are often associated, it is difficult to separate the effects of the alcohol abuse and smoking
(Hinkle 1405)
A 55-year-old man has been newly diagnosed with acute pancreatitis and admitted tothe acute medical unit. How should the nurse most likely explain the pathophysiology of this patient's health problem?
A)“Toxins have accumulated and inflamed your pancreas.”
B)“Bacteria likely migrated from your intestines and became lodged in your pancreas.”
C)“A virus that was likely already present in your body has begun to attack your
pancreatic cells.”
D)“The enzymes that your pancreas produces have damaged the pancreas itself.”
Ans:D
**A patient's assessment and diagnostic testing are suggestive of acute pancreatitis. Whenthe nurse is performing the health interview, what assessment questions address likely etiologic factors? Select all that apply.
A)“How many alcoholic drinks do you typically consume in a week?”
B)“Have you ever been tested for diabetes?”
C)“Have you ever been diagnosed with gallstones?”
D)“Would you say that you eat a particularly high-fat diet?”
E)“Does anyone in your family have cystic fibrosis?”
Ans:A, C
A nurse who provides care in a walk-in clinic assesses a wide range of individuals. Thenurse should identify which of the following patients as having the highest risk for chronic pancreatitis?
A)A 45-year-old obese woman with a high-fat diet
B)An 18-year-old man who is a weekend binge drinker
C)A 39-year-old man with chronic alcoholism
D)A 51-year-old woman who smokes one-and-a-half packs of cigarettes per day
Ans:C
A patient is receiving care in the intensive care unit for acute pancreatitis. The nurse isaware that pancreatic necrosis is a major cause of morbidity and mortality in patientswith acute pancreatitis. Consequently, the nurse should assess for what signs or symptoms of this complication?
A)Sudden increase in random blood glucose readings
B)Increased abdominal girth accompanied by decreased level of consciousness
C)Fever, increased heart rate and decreased blood pressure
D)Abdominal pain unresponsive to analgesics
Ans:C
4) Metabolism/Liver Failure/Nursing Care
NURSING DIAGNOSIS: Activity intolerance related to fatigue, lethargy, and malaise
Goal: Patient reports decrease in fatigue and reports increased ability to participate in activities
1. Assess level of activity tolerance and degree of fatigue, lethargy, and malaise when performing routine activities of daily living. Provides baseline for further assessment and criteria for assessment of effectiveness of interventions
2. Assist with activities and hygiene when fatigued. Promotes exercise and hygiene within patient’s level of tolerance.
3. Encourage rest when fatigued or when abdominal pain or discomfort occurs. Conserves energy and protects the liver
4. Assist with selection and pacing of desired activities and exercise. Stimulates patient’s interest in selected activities.
5. Provide diet high in carbohydrates with protein intake consistent with liver function. Provides calories for energy and protein for healing.
6. Administer supplemental vitamins (A, B complex, C, and K). Provides additional nutrients.
NURSING DIAGNOSIS: Imbalanced nutrition: less than body requirements related to abdominal distention and discomfort and anorexia
Goal: Positive nitrogen balance, no further loss of muscle mass; meets nutritional requirements
1. Assess dietary intake and nutritional status through diet history and diary, daily weight measurements, and laboratory data. Identifies deficits in nutritional intake and adequacy of nutritional state.
2. Provide diet high in carbohydrates with protein intake consistent with liver function. Provides calories for energy, sparing protein for healing.
3. Assist patient in identifying low sodium foods. Reduces edema and ascites formation.
4. Elevate the head of the bed during meals. Reduces discomfort from abdominal distention and decreases sense of fullness produced by pressure of abdominal contents and ascites on the stomach.
5. Provide oral hygiene before meals and pleasant environment for meals at mealtime.
Promotes positive environment and increased appetite; reduces unpleasant taste.
6. Offer smaller, more frequent meals (6/day). Decreases feeling of fullness, bloating.
7. Encourage patient to eat meals and supplementary feedings. Encouragement is essential for the patient with anorexia and gastrointestinal discomfort.
8. Provide attractive meals and an aesthetically pleasing setting at mealtime. Promotes appetite and sense of wellbeing.
9. Eliminate alcohol. Eliminates “empty calories” and further damage from alcohol.
10. Apply an ice collar for nausea. May reduce incidence of nausea.
Administer medications prescribed for nausea, vomiting, diarrhea, or constipation. Reduces gastrointestinal symptoms and discomforts that decrease the appetite and interest in food.
12. Encourage increased fluid intake and exercise if the patient reports constipation.
Promotes normal bowel pattern and reduces abdominal discomfort and distention.
NURSING DIAGNOSIS: Impaired skin integrity related to pruritus from jaundice and edema
Goal: Decrease potential for pressure ulcer development; breaks in skin integrity
1. Assess degree of discomfort related to pruritus and edema. Assists in determining appropriate interventions.
2. Note and record degree of jaundice and extent of edema. Provides baseline for detecting changes and evaluating effectiveness of interventions.
3. Keep patient’s fingernails short and smooth. Prevents skin excoriation and infection from scratching.
4. Provide frequent skin care; avoid the use of soaps and alcohol-based lotions. Removes waste products from skin while preventing dryness of skin.
5. Massage every 2 hours with emollients; turn every 2 hours. Promotes mobilization of edema.
6. Initiate use of alternating-pressure mattress or low air loss bed. Minimizes prolonged pressure on bony prominences susceptible to breakdown.
7. Recommend avoiding the use of harsh detergents. May decrease skin irritation and need for scratching.
8. Assess skin integrity every 4–8 hours. Instruct patient and family in this activity. Edematous skin and tissue have compromised nutrient supply and are vulnerable to pressure and trauma.
9. Restrict sodium as prescribed. Minimizes edema formation.
10. Perform range-of-motion exercises every 4 hours; elevate edematous extremities whenever possible. Promotes mobilization of edema.
NURSING DIAGNOSIS: Risk for injury related to altered clotting mechanisms and altered level of consciousness
Goal: Reduced risk of injury
1. Assess level of consciousness and cognitive level. Assists in determining patient’s ability to protect self and comply with required self-protective actions; may detect deterioration of hepatic function.
2. Provide safe environment (pad side rails, remove obstacles in room, prevent falls). Minimizes falls and injury if falls occur.
3. Provide frequent surveillance to orient patient, and avoid the use of restraints. Protects patient from harm while stimulating and orienting patient; the use of restraints may disturb patient further.
4. Replace sharp objects (razors) with safer items. Avoids cuts and bleeding.
5. Observe each stool for color, consistency, and amount. Permits detection of bleeding in gastrointestinal tract.
6. Be alert to symptoms of anxiety, epigastric fullness, weakness, and restlessness. May indicate early signs of bleeding and shock.
7. Test each stool and emesis for occult blood. Detects early evidence of bleeding.
8. Observe for hemorrhagic manifestations: ecchymosis, epistaxis, petechiae, and bleeding gums. Indicates altered clotting mechanisms.
9. Record vital signs at frequent intervals, depending on patient acuity (every 1–4 hours). Provides baseline and evidence of hypovolemia and hemorrhagic shock.
10. Keep patient quiet, and limit activity. Minimizes risk of bleeding and straining.
11. Assist physician in passage of tube for esophageal balloon tamponade, if its insertion is indicated. Promotes nontraumatic insertion of tube in anxious and combative patient for immediate treatment of bleeding.
12. Observe during blood transfusions. Permits detection of transfusion reactions (risk increased with multiple blood transfusions needed for active bleeding from esophageal varices).
13. Measure and record nature, time, and amount of vomitus. Assists in evaluating extent of bleeding and blood loss.
14. Maintain patient in fasting state, if indicated. Reduces risk of aspiration of gastric contents and minimizes risk of further trauma to esophagus and stomach by preventing vomiting.
15. Administer vitamin K as prescribed. Promotes clotting by providing fatsoluble vitamin necessary for clotting.
16. Remain with patient during episodes of bleeding. Reassures anxious patient and permits monitoring and detection of further needs of the patient.
17. Offer cold liquids by mouth when bleeding stops (if prescribed). Minimizes risk of further bleeding by promoting vasoconstriction of esophageal and gastric blood vessels.
18. Institute measures to prevent trauma. Promotes safety of patient.
a. Maintain safe environment. Minimizes risk of trauma and bleeding by avoiding falls and cuts, etc.
b. Encourage gentle blowing of nose. Reduces risk of nosebleed (epistaxis) secondary to trauma and decreased clotting.
c. Provide soft toothbrush, and avoid the use of toothpicks. Prevents trauma to oral mucosa while promoting good oral hygiene.
Encourage intake of foods with high content of vitamin C. Promotes healing.
e. Apply cold compresses where indicated. Minimizes bleeding into tissues by promoting local vasoconstriction.
f. Record location of bleeding sites. Permits detection of new bleeding sites and monitoring of previous sites of bleeding.
g. Use small-gauge needles for injections. Minimizes oozing and blood loss from repeated injections.
19. Administer medications carefully; monitor for side effects. Reduces risk of side effects secondary to damaged liver’s inability to detoxify (metabolize) medications normally.
NURSING DIAGNOSIS: Disturbed body image related to changes in appearance, sexual dysfunction, and role function
Goal: Patient verbalizes feelings consistent with improvement of body image and self-esteem
1. Assess changes in appearance and the meaning these changes have for patient and family. Provides information for assessing impact of changes in appearance, sexual function, and role on the patient and family.
2. Encourage patient to verbalize reactions and feelings about these changes. Enables patient to identify and express concerns; encourages patient and significant others to share these concerns.
3. Assess patient’s and family’s previous coping strategies. Permits encouragement of those coping strategies that are familiar to patient and have been effective in the past.
4. Assist and encourage patient to maximize appearance (such as strategies to limit the appearance of jaundice and ascites through careful selection of colors and type of clothing) and explore alternatives to previous sexual and role functions. Encourages patient to continue safe roles and functions while encouraging exploration of alternatives.
5. Assist patient in identifying short-term goals. Accomplishing these goals serves as positive reinforcement and increases self-esteem.
6. Encourage and assist patient in decision making about care. Promotes patient’s control of life and improves sense of well-being and self-esteem.
7. Identify with patient resources to provide additional support (counselor, spiritual advisor). Assists patient in identifying resources and accepting assistance from others when indicated.
8. Assist patient in identifying previous practices that may have been harmful to self (alcohol and drug abuse). Involve patient in goal setting, and provide positive feedback for accomplishments. Recognition and acknowledgment of the harmful effects of these practices are necessary for identifying a healthier lifestyle.
NURSING DIAGNOSIS: Chronic pain and discomfort related to enlarged tender liver and ascites
Goal: Increased level of comfort
1. Maintain bed rest when patient experiences abdominal discomfort. Reduces metabolic demands and protects the liver.
2. Administer antispasmodic and analgesic agents as prescribed. Reduces irritability of the gastrointestinal tract and decreases abdominal pain and discomfort.
3. Observe, record, and report presence and character of pain and discomfort. Provides baseline to detect further deterioration of status and to evaluate interventions.
4. Reduce sodium and fluid intake if prescribed. Minimizes further formation of ascites.
5. Prepare patient and assist with paracentesis. Removal of ascites fluid
6. Encourage the use of distracting activities such as music, reading, or meditation. Distraction may limit the perception of pain.
NURSING DIAGNOSIS: Fluid volume excess related to ascites and edema formation
Goal: Restoration of normal fluid volume
1. Restrict sodium and fluid intake if prescribed. Minimizes formation of ascites and edema.
2. Administer diuretic agents, potassium, and protein supplements as prescribed. Promotes excretion of fluid through the kidneys and maintenance of normal fluid and electrolyte balance.
3. Record intake and output every 1 to 8 hours depending on response to interventions and on patient acuity. Indicates effectiveness of treatment and adequacy of fluid intake.
4. Measure and record abdominal girth and weight daily. Monitors changes in ascites formation and fluid accumulation.
5. Explain rationale for sodium and fluid restriction. Promotes patient’s understanding of restriction and cooperation with it.
6. Prepare patient and assist with paracentesis. Paracentesis will temporarily decrease amount of ascites present.
NURSING DIAGNOSIS: Confusion related to abnormal liver function and increased serum ammonia level
Goal: Improved mental status; safety maintained; ability to cope with cognitive and behavioral changes
1. Restrict dietary protein as prescribed for transient period. Reduces source of ammonia (protein foods).
2. Give frequent, small feedings of carbohydrates. Promotes consumption of adequate carbohydrates for energy requirements and spares protein from breakdown for energy.
3. Protect from infection. Minimizes risk of further increase in metabolic requirements.
4. Keep environment warm and draft free. Minimizes shivering, which would increase metabolic requirements.
5. Pad the side rails of the bed. Provides protection for the patient should hepatic coma and seizure activity occur.
6. Limit visitors. Minimizes patient’s activity and metabolic requirements.
7. Provide careful nursing surveillance to ensure patient’s safety. Provides close monitoring of new symptoms and minimizes trauma to the confused patient.
8. Avoid opioids and barbiturates. Prevents masking of symptoms of hepatic coma and prevents drug overdose secondary to reduced ability of the damaged liver to metabolize opioids and barbiturates; prevents respiratory depression.
9. Awaken at intervals (every 2–4 hours) to assess cognitive status. Provides stimulation to the patient and opportunity for observing patient’s level of consciousness.
10. Identify subtle changes in behavior or sleep–wake pattern (consistent staff caring for the patient enhances this assessment as they become familiar with patient’s baseline). These changes may herald worsening of encephalopathy, which requires rapid intervention, including medication.
11. Assess handwriting or drawing skill daily as indication of cognitive ability. These changes may herald worsening of encephalopathy, which requires rapid intervention, including medication.
12. Encourage patient and family to participate in therapeutic strategies to enhance coping with episodes of mental deterioration. Promoting activities such as listening to music, relaxation techniques, or pre-illness coping strategies can reduce anxiety.
13. Encourage patient and family to discuss feeling of fear, powerlessness, or emotional distress related to patient’s mental deterioration. Actively listening demonstrates caring and concern.
NURSING DIAGNOSIS: Risk for imbalanced body temperature: hyperthermia related to inflammatory process of cirrhosis or hepatitis
Goal: Maintenance of normal body temperature, free from infection
1. Record temperature regularly (every 4 hours). Provides baseline to detect fever and to evaluate interventions.
2. Encourage fluid intake. Corrects fluid loss from perspiration and fever and increases patient’s level of comfort.
3. Apply cool sponges or ice bag for elevated temperature. Promotes reduction of fever and increases patient’s comfort.
4. Administer antibiotics as prescribed. Ensures appropriate serum concentration of antibiotics to treat infection.
5. Avoid exposure to infections. Minimizes risk of further infection and further increases in body temperature and metabolic rate.
6. Keep patient at rest while temperature is elevated. Reduces metabolic rate.
7. Assess for abdominal pain, tenderness. May occur with bacterial peritonitis.
8. Use sterile technique for all invasive procedures. Many evidence-based practice guidelines (e.g., central venous catheter care) recommend the use of sterile technique to prevent nosocomial infections.
NURSING DIAGNOSIS: Ineffective breathing pattern related to ascites and restriction of thoracic excursion secondary to ascites, abdominal distention, and fluid in the thoracic cavity
Goal: Improved respiratory status
1. Elevate head of bed to at least 30 degrees. Reduces abdominal pressure on the diaphragm and permits fuller thoracic excursion and lung expansion.
2. Conserve patient’s strength by providing rest periods and assisting with activities. Reduces metabolic and oxygen requirements.
3. Change position every 2 hours. Promotes expansion and oxygenation of all areas of the lungs.
4. Assist with paracentesis or thoracentesis. Paracentesis and thoracentesis (performed to remove fluid from the abdominal and thoracic cavities, respectively) may be frightening to the patient.
a. Explain procedure and its purpose to patient. Helps obtain patient’s cooperation with procedures.
b. Have patient void before paracentesis. Prevents inadvertent bladder injury.
c. Support and maintain position during procedure. Prevents inadvertent organ or tissue injury.
d. Record both the amount and the character of fluid aspirated. Provides record of fluid removed and indication of severity of limitation of lung expansion by fluid.
e. Observe for evidence of coughing, increasing dyspnea, or pulse rate. Indicates irritation of the pleural space and evidence of pneumothorax or hemothorax.
COLLABORATIVE PROBLEM: Gastrointestinal bleeding and hemorrhage
Goal: Absence of episodes of gastrointestinal bleeding and hemorrhage
1. Assess patient for evidence of gastrointestinal bleeding or hemorrhage. If bleeding does occur: Allows early detection of signs and symptoms of bleeding and hemorrhage.
a. Monitor vital signs (blood pressure, pulse, respiratory rate) every 4 hours or more frequently, depending on acuity.
b. Assess skin temperature, level of consciousness every 4 hours or more frequently, depending on acuity.
c. Monitor gastrointestinal secretions and output (emesis, stool for occult or obvious bleeding). Test emesis for blood once per shift and with any color change. Hematest each stool.
d. Monitor hematocrit and hemoglobin for trends and changes.
2. Avoid activities that increase intraabdominal pressure (straining, turning). Minimizes increases in intra-abdominal pressure that could lead to rupture and bleeding of esophageal or gastric varices.
a. Avoid coughing/sneezing.
b. Assist patient to turn.
c. Keep all needed items within easy reach.
d. Use measures to prevent constipation such as adequate fluid intake, stool softeners.
e. Ensure small meals.
3. Have equipment (Sengstaken-Blakemore tube™, medications, IV fluids) available if indicated. Equipment, medications, and supplies will be readily available if patient experiences bleeding from ruptured esophageal or gastric varices.
4. Assist with procedures and therapy needed to treat gastrointestinal bleeding and hemorrhage. Gastrointestinal bleeding and hemorrhage require emergency measures (e.g., insertion of Sengstaken-Blakemore tube™, administration of fluids and medications).
5. Monitor respiratory status every hour, and minimize risk of respiratory complications if balloon tamponade is needed. The patient is at high risk for respiratory complications, including asphyxiation if gastric balloon of tamponade tube ruptures or migrates upward.
6. Prepare patient physically and psychologically for other treatment modalities if needed. The patient who experiences hemorrhage is very anxious and fearful; minimizing anxiety assists in control of hemorrhage.
7. Monitor patient for recurrence of bleeding and hemorrhage. Risk of rebleeding is high with all treatment modalities used to halt gastrointestinal bleeding.
8. Keep family informed of patient’s status. Family members are likely to be anxious about the patient’s status; providing information will reduce their anxiety level and promote more effective coping.
9. Once recovered from bleeding episode, provide patient and family with information regarding signs and symptoms of gastrointestinal bleeding. Risk of rebleeding is high. Subtle signs may be more quickly identified.
COLLABORATIVE PROBLEM: Hepatic encephalopathy
Goal: Absence of changes in cognitive status and of injury
1. Assess cognitive status every 4–8 hours. Data will provide baseline of patient’s cognitive status and enable detection of changes.
a. Assess patient’s orientation to person, place, and time.
b. Monitor patient’s level of activity, restlessness, and agitation. Assess for presence of flapping hand tremors (asterixis).
c. Obtain and record daily sample of patient’s handwriting or ability to construct a simple figure (e.g., star).
d. Assess neurologic signs (deep tendon reflexes, ability to follow instructions).
2. Monitor medications to prevent administration of those that may precipitate hepatic encephalopathy (sedative, hypnotic, analgesic agents). Medications are a common precipitating factor in development of hepatic encephalopathy in patients at risk.
3. Monitor laboratory data, especially serum ammonia level. Increases in serum ammonia level are associated with hepatic encephalopathy and coma.
4. Notify physician of even subtle changes in patient’s neurologic assessment, cognitive function, sleep pattern, or mood. Allows early initiation of treatment of hepatic encephalopathy and prevention of hepatic coma.
5. Limit sources of protein from diet if indicated. Reduces breakdown and conversion of protein to ammonia.
6. Administer medications prescribed to reduce serum ammonia level (e.g., lactulose, antibiotics, glucose, benzodiazepine antagonist [flumazenil] if indicated). Reduces serum ammonia level.
7. Assess respiratory status, and initiate measures to prevent complications. The patient who develops hepatic coma is at risk for respiratory complications (i.e., pneumonia, atelectasis, infection).
8. Protect patient’s skin and tissue from pressure and breakdown. The patient in coma is at risk for skin breakdown and pressure ulcer formation.
9. Provide support and active listening for patient and family as patient’s mental status deteriorates. The patient with hepatic encephalopathy can experience episodes of mental deterioration due to liver failure. This can produce feelings of fear and anxiety.
(Hinkle 1369-1376) Brunner 13th edition
A patient is being discharged after a liver transplant and the nurse is performingdischarge education. When planning this patient's continuing care, the nurse shouldprioritize which of the following risk diagnoses?
A)Risk for Infection Related to Immunosuppressant Use
B)Risk for Injury Related to Decreased Hemostasis
C)Risk for Unstable Blood Glucose Related to Impaired Gluconeogenesis
D)Risk for Contamination Related to Accumulation of Ammonia
Ans:A
Feedback:Infection is the leading cause of death after liver transplantation.
A patient with end-stage liver disease has developed hypervolemia. What nursing interventions would be most appropriate when addressing the patient's fluid volumeexcess? Select all that apply.
A)Administering diuretics
B)Administering calcium channel blockers
C)Implementing fluid restrictions
D)Implementing a 1500 kcal/day restriction
E)Enhancing patient positioning
Ans: A, C, E
Feedback:Administering diuretics, implementing fluid restrictions, and enhancing patientpositioning can optimize the management of fluid volume excess.
A patient with liver cancer is being discharged home with a biliary drainage system inplace. The nurse should teach the patient's family how to safely perform which of thefollowing actions?
A)Aspirating bile from the catheter using a syringe
B)Removing the catheter when output is≤15 mL in 24 hours
C)Instilling antibiotics into the catheter
D)Assessing the patency of the drainage catheter
Ans:D
*A patient with cirrhosis has experienced a progressive decline in his health; and livertransplantation is being considered by the interdisciplinary team. How will the patient'sprioritization for receiving a donor liver be determined?
A)By considering the patient's age and prognosis
B)By objectively determining the patient's medical need
C)By objectively assessing the patient's willingness to adhere to post-transplantation care
D)By systematically ruling out alternative treatment options
Ans:B
Feedback:
The patient would undergo a classification of the degree of medical need through anobjective determination known as the Model of End-Stage Liver Disease (MELD)
A patient with liver cancer is being discharged home with a hepatic artery catheter inplace. The nurse should be aware that this catheter will facilitate which of the following?
A)Continuous monitoring for portal hypertension
B)Administration of immunosuppressive drugs during the first weeks after transplantation
C)Real-time monitoring of vascular changes in the hepatic system
D)Delivery of a continuous chemotherapeutic dose
Ans:D
A nurse on a solid organ transplant unit is planning the care of a patient who will soonbe admitted upon immediate recovery following liver transplantation. What aspect of nursing care is the nurse's priority?
A)Implementation of infection-control measures
B)Close monitoring of skin integrity and color
C)Frequent assessment of the patient's psychosocial status
D)Administration of antiretroviral medications
Ans:A
5) Pancreatitis -Pain Management
Pain Management
• Adequate administration of analgesia is essential during the course of acute pancreatitis to provide sufficient pain relief and to minimize restlessness, which may stimulate pancreatic secretion further. Pain relief may require parenteral opioids such as morphine, fentanyl (Sublimaze), or hydromorphone (Dilaudid). There is no clinical evidence to support the use of meperidine for pain relief in pancreatitis; in fact, accumulation of its metabolites can cause CNS irritability and possibly seizures. The current recommendation for pain management is the use of opioids, with assessment for their effectiveness and altering therapy if pain is not controlled or increased. More research is needed to identify the best option for pain management in the patient with acute pancreatitis. Antiemetic agents may be prescribed to prevent vomiting. (Hinkle 1403)
Nursing Management
Relieving Pain and Discomfort
• Because the pathologic process responsible for pain is autodigestion of the pancreas, the objectives of therapy are to relieve pain and decrease secretion of pancreatic enzymes. The pain of acute pancreatitis is often very severe, necessitating the liberal use of analgesic agents. The current recommendation for pain management in this population is parenteral opioids, including morphine, hydromorphone, or fentanyl via patient controlled analgesia or bolus. In critically ill patients, a continuous infusion may be needed. Because most opioids stimulate spasm of the sphincter of Oddi to some degree, consensus has not been reached on the most effective agent. Ensuring patient comfort, regardless of the opioid prescribed, is the most essential aspect of care. The nurse frequently assesses the pain and the effectiveness of the pharmacologic (and nonpharmacologic) interventions. Changes may be needed in the regimen for pain management based on the achievement of pain control. Pain assessment tools (see Chapter 12) are available for the nurse to ensure an accurate rating of pain. Nonpharmacologic interventions such as proper positioning, music, distraction, and imagery may be effective in reducing pain when used along with medications.
• In addition, oral feedings are withheld to decrease the secretion of secretin. Parenteral fluids and electrolytes are prescribed to restore and maintain fluid balance. Nasogastric suction may be used to relieve nausea and vomiting or to treat abdominal distention and paralytic ileus. The nurse provides frequent oral hygiene and care to decrease discomfort from the nasogastric tube and relieve dryness of the mouth.
• The acutely ill patient is maintained on bed rest to decrease the metabolic rate and reduce the secretion of pancreatic and gastric enzymes. If the patient experiences increasing severity of pain, the nurse reports this to the physician because the patient may be experiencing hemorrhage of the pancreas or the dose of analgesic medication may be inadequate.
• The patient with acute pancreatitis often has a clouded sensorium because of severe pain, fluid and electrolyte disturbances, and hypoxia. Therefore, the nurse provides frequent and repeated but simple explanations about the need for withholding fluids, maintenance of gastric suction, and bed rest.
(Hinkle 1404) Brunner 13th edition
A 37-year-old male patient presents at the emergency department (ED) complaining ofnausea and vomiting and severe abdominal pain. The patient's abdomen is rigid, andthere is bruising to the patient's flank. The patient's wife states that he was on a drinkingbinge for the past 2 days. The ED nurse should assist in assessing the patient for what health problem?
A)Severe pancreatitis with possible peritonitis
B)Acute cholecystitis
C)Chronic pancreatitis
D)Acute appendicitis with possible perforation
Ans:A
*A patient with chronic pancreatitis had a pancreaticojejunostomy created 3 months agofor relief of pain and to restore drainage of pancreatic secretions. The patient has cometo the office for a routine postsurgical appointment. The patient is frustrated that thepain has not decreased. What is the most appropriate initial response by the nurse?
A)"The majority of patients who have a pancreaticojejunostomy have their normal
digestion restored but do not achieve pain relief."
B) "Pain relief occurs by 6 months in most patients who undergo this procedure, butsome people experience a recurrence of their pain."
C)"Your physician will likely want to discuss the removal of your gallbladder to
achieve pain relief."
D)"You are probably not appropriately taking the medications for your pancreatitis
and pain, so we will need to discuss your medication regimen in detail."
Ans:B
A patient is being treated on the acute medical unit for acute pancreatitis. The nurse hasidentified a diagnosis of Ineffective Breathing Pattern Related to Pain. Whatintervention should the nurse perform in order to best address this diagnosis?
A)Position the patient supine to facilitate diaphragm movement.
B)Administer corticosteroids by nebulizer as ordered.
C)Perform oral suctioning as needed to remove secretions.
D)Maintain the patient in a semi-Fowler's position whenever possible.
Ans:D
A community health nurse is caring for a patientwhose multiple health problems include chronic pancreatitis. During the most recent visit, the nurse notes that the patient is experiencing severe abdominal pain and has vomited 3 times in the past several hours. What is the nurse's most appropriate action?
A)Administer a PRN dose of pancreatic enzymes as ordered.
B)Teach the patient about the importance of abstaining from alcohol.
C)Arrange for the patient to be transported to the hospital.
D)Insert an NG tube, if available, and stay with the patient.
Ans:C
**A patient has been diagnosed with acute pancreatitis. The nurse is addressing thediagnosis of Acute Pain Related to Pancreatitis. What pharmacologic intervention ismost likely to be ordered for this patient?
A)Oral oxycodone
B)IV hydromorphone (Dilaudid)
C)IM meperidine (Demerol)
D)Oral naproxen (Aleve)
Ans:B
Feedback:
The pain of acute pancreatitis is often very severe and pain relief may require parenteral
opioids such as morphine, fentanyl (Sublimaze), or hydromorphone (Dilaudid). There is
no clinical evidence to support the use of meperidine for pain relief in pancreatitis.
A patient has just been diagnosed with chronic pancreatitis. The patient is underweight
and in severe pain and diagnostic testing indicates that over 80% of the patient's
pancreas has been destroyed. The patient asks the nurse why the diagnosis was not
made earlier in the disease process. What would be the nurse's best response?
A)“The symptoms of pancreatitis mimic those of much less serious illnesses.”
B)“Your body doesn't require pancreatic function until it is under great stress, so it
is easy to go unnoticed.”
C)“Chronic pancreatitis often goes undetected until a large majority of pancreatic function is lost.”
D)“It's likely that your other organs were compensating for your decreased pancreatic function.”
Ans:C
6) Pancreatitis- Medical Management
Medical Management of Acute Pancreatitis
• Management of acute pancreatitis is directed toward relieving symptoms and preventing or treating complications. All oral intake is withheld to inhibit stimulation of the pancreas and its secretion of enzymes. Parenteral nutrition plays an important role in the nutritional support of patients with severe acute pancreatitis, particularly in those who are debilitated and those with a prolonged paralytic ileus (more than 48 to 72 hours) (Townsend et al., 2012; Wu & Conwell, 2010). Ongoing research has shown positive outcomes with the use of enteral feedings.
• The current recommendation is that, whenever possible, the enteral route should be used to meet nutritional needs in patients with pancreatitis. This strategy also has been found to prevent infectious complications safely and cost-effectively (Townsend et al., 2012; Wu & Conwell, 2010). Enteral feedings should be started early in the course of acute pancreatitis. Patients who do not tolerate enteral feeding require parenteral nutrition. Nasogastric suction may be used to relieve nausea and vomiting and to decrease painful abdominal distention and paralytic ileus.
• Research data do not support the routine use of nasogastric tubes to remove gastric secretions in an effort to limit pancreatic secretion. Histamine-2 (H2) antagonists such as cimetidine (Tagamet) and ranitidine (Zantac) may be prescribed to decrease pancreatic activity by inhibiting secretion of gastric acid. Proton pump inhibitors such as pantoprazole (Protonix) may be used for patients who do not tolerate H2 antagonists or for whom this therapy is ineffective (Karch, 2012).
Pain Management
• Adequate administration of analgesia is essential during the course of acute pancreatitis to provide sufficient pain relief and to minimize restlessness, which may stimulate pancreatic secretion further.Pain relief may require parenteral opioids such as morphine, fentanyl (Sublimaze), or hydromorphone (Dilaudid) (Rakel&Rakel, 2011).
o There is no clinical evidence to support the use of meperidine for pain relief in pancreatitis; in fact, accumulation of its metabolites can cause CNS irritability and possibly seizures. The current recommendation for pain management is the use of opioids, with assessment for their effectiveness and altering therapy if pain is not controlled or increased (Marx, 2009). More research is needed to identify the best option for pain management in the patient with acute pancreatitis (Marx, 2009). Antiemetic agents may be prescribed to prevent vomiting.
Intensive Care
• Correction of fluid and blood loss and low albumin levels is necessary to maintain fluid volume and prevent renal failure. The patient is usually acutely ill and is monitored in the intensive care unit, where hemodynamic monitoring and arterial blood gas monitoring are initiated. Antibiotic agents may be prescribed if infection is present.
o The role of prophylactic antibiotics is controversial and still under study. Insulin may be required if hyperglycemia occurs. Intensive insulin therapy (continuous infusion) in the critically ill patient has undergone much study and has shown promise in terms of positive patient outcomes when compared with intermittent insulin dosing.
o Glycemic control with normal or near-normal blood glucose levels improves patient outcomes (Griesdale, 2009).
Respiratory Care
• Aggressive respiratory care is indicated because of the high risk of elevation of the diaphragm, pulmonary infiltrates and effusion, and atelectasis. Hypoxemia occurs in a significant number of patients with acute pancreatitis, even with normal x-ray findings. Respiratory care may range from close monitoring of arterial blood gases to the use of humidified oxygen to intubation and mechanical ventilation (see Chapter 21 for further discussion).
Biliary Drainage
• Placement of biliary drains (for external drainage) and stents (indwelling tubes) in the pancreatic duct through endoscopy has been performed to reestablish drainage of the pancreas. This has resulted in decreased pain and increased weight gain.
Surgical Intervention
• Although the acutely ill patient is at high risk for surgical complications, surgery may be performed to assist in the diagnosis of pancreatitis (diagnostic laparotomy); to establish pancreatic drainage; or to resect or débride an infected, necrotic pancreas.
• The patient who undergoes pancreatic surgery may have multiple drains in place postoperatively, as well as a surgical incision that is left open for irrigation and repacking every 2 to 3 days to remove necrotic debris (Fig. 50-6).
Postacute Management
• Oral feedings that are low in fat and protein are initiated gradually. Caffeine and alcohol are eliminated from the diet. If the episode of pancreatitis occurred during treatment with thiazide diuretics, corticosteroids, or oral contraceptives, these medications are discontinued.
• Follow-up may include ultrasound, x-ray studies, or ERCP to determine whether the pancreatitis is resolving and to assess for abscesses and pseudocysts. ERCP may also be used to identify the cause of acute pancreatitis if it is in question and for endoscopic sphincterotomy and removal of gallstones from the common bile duct.
Brunner Ch 50 Pg 1408
Medical Management of Chronic Pancreatitis
• The management of chronic pancreatitis depends on its probable cause in each patient. Treatment is directed toward preventing and managing acute attacks, relieving pain and discomfort, and managing exocrine and endocrine insufficiency of pancreatitis.
Nonsurgical Management
• Nonsurgical approaches may be indicated for the patient who refuses surgery, is a poor surgical risk, or when the disease and symptoms do not warrant surgical intervention. Endoscopy to remove pancreatic duct stones, correct strictures, and drain cysts may be effective in selected patients to manage pain and relieve obstruction via ERCP (Trikudanathan et al., 2012).
• Management of abdominal pain and discomfort is similar to that of acute pancreatitis; however, the focus is usually on the use of nonopioid methods to manage pain and the implementation of the World Health Organization’s (WHO) three-step ladder for the treatment of chronic pain. This involves initiating monotherapy and, if ineffective, instituting combination therapy with peripherally acting and centrally acting medications.
• Antioxidants have shown effect in the relief of pain and in improving quality of life and are often administered to patients with chronic pancreatitis (Trikudanathan et al., 2012). Researchers have proposed that yoga may be an effective nonpharmacologic method for pain reduction and for relief of other coexisting symptoms of chronic pancreatitis (Trikudanathan et al., 2012). Persistent, unrelieved pain is often the most difficult aspect of management (Trikudanathan et al., 2012).
• The primary provider, nurse, and dietitian emphasize to the patient and family the importance of avoiding alcohol and foods that have produced abdominal pain and discomfort in the past. The health care team stresses to the patient that no other treatment is likely to relieve pain if the patient continues to consume alcohol.
• Diabetes resulting from dysfunction of the pancreatic islet cells is treated with diet, insulin, or oral antidiabetic agents.
• The hazard of severe hypoglycemia with alcohol consumption is stressed to the patient and family. Pancreatic enzyme replacement is indicated for the patient with malabsorption and steatorrhea.
Surgical Management
• Chronic pancreatitis is not often managed by surgery. However, surgery may be indicated to relieve persistent abdominal pain and discomfort, restore drainage of pancreatic secretions, and reduce the frequency of acute attacks of pancreatitis and hospitalization (Trikudanathan et al., 2012). The type of surgery performed depends on the anatomic and functional abnormalities of the pancreas, including the location of disease within the pancreas, the presence of diabetes, exocrine insufficiency, biliary stenosis, and pseudocysts of the pancreas.
• Other considerations for surgery selection include the patient’s likelihood for continued use of alcohol and the likelihood that the patient will be able to manage the endocrine or exocrine changes that are expected after surgery.
• Pancreaticojejunostomy (also referred to as Roux-en-Y), with a side-to-side anastomosis or joining of the pancreatic duct to the jejunum, allows drainage of the pancreatic secretions into the jejunum.
o Pain relief occurs within 6 months in more than 85% of the patients who undergo this procedure, but pain returns in a substantial number of patients as the disease progresses (Trikudanathan et al., 2012).
• Other surgical procedures may be performed for different degrees and types of underlying disorders. These procedures include revision of the sphincter of the ampulla of Vater, internal drainage of a pancreatic cyst into the stomach (see later discussion), insertion of a stent, and wide resection or removal of the pancreas.
• A Whipple resection (pancreaticoduodenectomy) can be carried out to relieve the pain of chronic pancreatitis (see later discussion under Tumors of the Head of the Pancreas). In an effort to provide permanent pain relief and avoid endocrine and exocrine insufficiency that ensue with major resections of the pancreas, surgeons have designed new procedures that combine limited resection of the head of the pancreas with a pancreaticojejunostomy.
o These procedures, known as the Beger or Frey operations, remove most of the head of the pancreas except for a shell of pancreatic tissue posteriorly (Trikudanathan et al., 2012).
• When chronic pancreatitis develops as a result of gallbladder disease, surgery is performed to explore the common duct and remove the stones; usually, the gallbladder is removed at the same time. In addition, an attempt is made to improve the drainage of the common bile duct and the pancreatic duct by dividing the sphincter of Oddi, a muscle that is located at the ampulla of Vater (this surgical procedure is known as a sphincterotomy).
• A T-tube usually is placed in the common bile duct, requiring a drainage system to collect the bile postoperatively. Nursing care after such surgery is similar to that indicated after other biliary tract surgery.
• Approximately two thirds of all patients with chronic pancreatitis can be managed with endoscopic or laparoscopic intervention (Yamada, 2009). Endoscopic and laparoscopic procedures such as distal pancreatectomy, longitudinal decompression of the pancreatic duct, nerve denervation, and stenting have been performed in patients with jaundice or recurrent inflammation and are being refined.
• Minimally invasive procedures to treat chronic pancreatitis may prove to be successful adjuncts in the management of this complex disorder (Trikudanathan et al., 2012).
• Patients who undergo surgery for chronic pancreatitis may experience weight gain and improved nutritional status; this may result from reduction in pain associated with eating rather than from correction of malabsorption.
• However, morbidity and mortality after these surgical procedures are high because of the poor physical condition of the patient before surgery and the concomitant presence of cirrhosis. Even after undergoing these surgical procedures, the patient is likely to continue to have pain and impaired digestion secondary to pancreatitis.
A 37-year-old male patient presents at the emergency department (ED) complaining ofnausea and vomiting and severe abdominal pain. The patient's abdomen is rigid, and there is bruising to the patient's flank. The patient's wife states that he was on a drinking binge for the past 2 days. The ED nurse should assist in assessing the patient for what health problem?
A)Severe pancreatitis with possible peritonitis
B)Acute cholecystitis
C)Chronic pancreatitis
D)Acute appendicitis with possible perforation
Ans:A
A home health nurse is caring for a patient discharged home after pancreaticSurgery. The nurse documents the nursing diagnosis Risk for Imbalanced Nutrition: Less thanBody Requirements on the care plan based on the potential complications that mayoccur after surgery. What are the most likely complications for the patient who has had pancreatic surgery?
A)Proteinuria and hyperkalemia
B)Hemorrhage and hypercalcemia
C)Weight loss and hypoglycemia
D)Malabsorption and hyperglycemia
Ans:D
Feedback:
The nurse arrives at this diagnosis based on the complications of malabsorption and hyperglycemia.
A nurse is creating a care plan for a patient with acute pancreatitis. The care plan includes reduced activity. What rationale for this intervention should be cited in the care plan?
A)Bed rest reduces the patient's metabolism and reduces the risk of metabolic acidosis.
B) Reduced activity protects the physical integrity of pancreatic cells.
C)Bed rest lowers the metabolic rate and reduces enzyme production.
D)In activity reduces caloric need and gastrointestinal motility.
Ans:C
An adult patient has been admitted to the medical unit for the treatment of acutepancreatitis. What nursing action should be included in this patient's plan of care?
A)Measure the patient's abdominal girth daily.
B)Limit the use of opioid analgesics.
C)Monitor the patient for signs of dysphagia.
D) Encourage activity as tolerated.
Ans:A
Feedback:Due to the risk of ascites, the nurse should monitor the patient's abdominal girth.
7) Metabolism/Liver Failure/Nursing Care
Brunner Ch 49 pg 1366
Nursing Management
• Nursing management for the patient with cirrhosis of the liver is described in detail in Chart49-12. Nursing interventions are directed toward promoting patient’s rest, improving nutritional status, providing skin care, reducing risk of injury, and monitoring and managing potential complications.
Promoting Rest
The patient with cirrhosis requires rest and other supportive measures to permit the liver to reestablish its functional ability. If the patient is hospitalized, weight and I&O are measured and recorded daily. The nurse adjusts the patient’s position in bed for maximal respiratory efficiency, which is especially important if ascites is marked, because it interferes with adequate thoracic excursion. Oxygen therapy may be required in liver failure to oxygenate the damaged cells and prevent further cell destruction.
Rest reduces the demands on the liver and increases the liver’s blood supply. Because the patient is susceptible to the hazards of immobility, efforts to prevent respiratory, circulatory, and vascular disturbances are initiated. These measures may help prevent such problems as pneumonia, thrombophlebitis, and pressure ulcers. After nutritional status improves and strength increases, the nurse encourages the patient to increase activity gradually. Activity and mild exercise, as well as rest, are planned.
Improving Nutritional Status
The patient with cirrhosis without ascites, edema, or signs of impending hepatic coma should receive a nutritious, highprotein diet, if tolerated, supplemented by vitamins of the B complex, as well as A, C, and K. The nurse encourages the patient to eat. If ascites is present, small, frequent meals may be better tolerated than three large meals because of the abdominal pressure exerted by ascites.
Imbalance of the intestinal flora is not uncommon. Research suggests that the oral ingestion of 1 cup of probiotic yogurt three times a day reduces intestinal flora imbalance by decreasing Escherichia coli counts (Liu, Zhang, Zhang, et al., 2010).
Patients with fatty stools (steatorrhea) should receive watersoluble forms of fat-soluble vitamins A, D, and E (Aquasol A, D, and E). Folic acid and iron are prescribed to prevent anemia. If the patient shows signs of impending or advancing coma despite medical interventions, the amount of protein in the diet may be decreased temporarily. Protein is restricted if encephalopathy develops that cannot be effectively managed with lactulose and other medical treatment strategies. Incorporating vegetable protein to meet protein needs may decrease the risk for encephalopathy. Sodium restriction is also indicated to prevent ascites. Patients with prolonged or severe anorexia and those who are vomiting or eating poorly for any reason may receive nutrients by the enteral or parenteral route.
Providing Skin Care
Providing careful skin care is important because of subcutaneous edema, the patient’s immobility, jaundice, and increased susceptibility to skin breakdown and infection. Frequent changes in position are necessary to prevent pressure ulcers. Irritating soaps and the use of adhesive tape are avoided to prevent trauma to the skin. Lotion may be soothing to irritated skin; the nurse takes measures to minimize scratching by the patient.
Reducing Risk of Injury
The nurse protects the patient with cirrhosis from falls and other injuries. The side rails should be in place and pads used in case the patient becomes agitated or restless. To minimize agitation, the nurse orients the patient to time and place and explains all procedures. The nurse instructs the patient to ask for assistance to get out of bed. The nurse carefully evaluates any injury because of the possibility of internal bleeding.
Because of the risk for bleeding from abnormal clotting, the patient should use an electric razor rather than a safety razor. A soft-bristled toothbrush helps minimize bleeding gums, and pressure applied to all venipuncture sites helps minimize bleeding.
Monitoring and Managing Potential Complications
A major role of the nurse is monitoring of the patient with cirrhosis for complications.
Bleeding and Hemorrhage
The patient is at increased risk for bleeding and hemorrhage because of decreased production of prothrombin and decreased ability of the diseased liver to synthesize the necessary substances for blood coagulation (see the Esophageal Varices section).
Hepatic Encephalopathy
Hepatic encephalopathy and coma, which are complications of cirrhosis, may manifest as deteriorating mental status and dementia or as physical signs such as abnormal voluntary and involuntary movements. Hepatic encephalopathy was discussed earlier in the chapter in detail.
Monitoring is essential to identify early deterioration in mental status. The nurse monitors the patient’s mental status closely and reports changes so that treatment for encephalopathy can be initiated promptly. An extensive baseline and ongoing neurologic evaluation is key to identify progression through the four stages of encephalopathy (see Table 49-3).
Each advancing stage demands more intensive nursing interventions aimed at providing for patient safety and prevention and early identification of life-threatening complications such as respiratory failure and cerebral edema, which would necessitate interventions in an ICU. Because electrolyte disturbances can contribute to encephalopathy, serum electrolyte levels are carefully monitored and corrected if abnormal. Oxygen is administered if oxygen desaturation occurs. The nurse monitors for fever or abdominal pain, which may signal the onset of bacterial peritonitis or other infection (see earlier discussion of hepatic encephalopathy).
Fluid Volume Excess
Patients with advanced chronic liver disease develop cardiovascular abnormalities. These occur due to an increased cardiac output and decreased peripheral vascular resistance, possibly resulting from the release of vasodilators. A hyperdynamic circulatory state develops in patients with cirrhosis, and plasma volume increases. This increase in circulating plasma volume is probably multifactorial, but some studies have implicated excess production of nitrous oxide, such as that seen in sepsis, as one causative factor (Gordon, 2012). The greater the degree of hepatic decompensation, the more severe the hyperdynamic state. Close assessment of cardiovascular and respiratory status is of key importance for the care of patients with this disorder. Pulmonary compromise is always a potential complication of ESLD because of plasma volume excess; consequently, the nurse has an important role in preventing pulmonary complications. Administering diuretic agents, implementing fluid restrictions, and enhancing patient positioning can optimize pulmonary function. Fluid retention may be noted in the development of ascites, lower extremity swelling, and dyspnea. Monitoring of I&O, daily weight changes, changes in abdominal girth, and edema formation is part of nursing assessment in the hospital or in the home setting. Patients are also monitored for nocturia and, later, for oliguria, because these states indicate increasing severity of liver dysfunction (Gordon, 2012).
8)Metabolism/ Failure to Thrive/Causes
Ricci Ch 34 pg 1244
FTT is a multifactorial problem. Developmental disability (mental or physical or combination impairment resulting in lifelong disability) may contribute to FTT, as the child’s ability to consume adequate nutrition is impaired because of sensory or motor delays, such as with cerebral palsy. Other organic causes of FTT include inability to suck and/or swallow correctly, malabsorption, diarrhea, vomiting, or alterations in metabolism and caloric/nutrient needs associated with a variety of chronic illnesses. Infants and children with cardiac or metabolic disease, chronic lung disease (bronchopulmonary dysplasia), cleft palate, or gastroesophageal reflux disease are at particular risk. Feeding disorders or food refusal may occur in infants or children who have required prolonged mechanical ventilation, long-term enteral tube feedings, or an unpleasant event such as a choking episode. Additional causes of FTT include neglect, abuse, behavioral problems, lack of appropriate maternal interaction, poor feeding techniques, lack of parental knowledge, or parental mental illness. Poverty is the single greatest contributing risk factor (Kirkland &Motil, 2015a; Starr et al., 2013)
9) Metabolism/ Failure to Thrive
Screen all children for FTT to identify them early. In addition to poor growth, the infant or child with FTT may present with a history of developmental delay or loss of acquired milestones. Infants or children with feeding problems may display nipple, spoon, or food refusal; difficulty sucking; disinterest in feeding; or difficulty progressing from liquid to puréed to textured food. Perform a detailed dietary history and instruct the parents to complete a 3-day food diary to identify what the child actually eats and drinks. Assess the parent–child interaction, with particular attention to the parent’s ability to read and respond to the infant’s or child’s cues. Observe feeding, noting the child’s oral interest or aversion, oral–motor coordination, and swallowing ability, as well as parent–child interactions before, during, and after the feeding
NURSING INTERVENTIONS DURING THE CHILD’S HOSPITALIZATION FOR FAILURE TO THRIVE
• Observe parent–child interactions, especially during feedings.
• Develop an appropriate feeding schedule.
• Provide feedings as prescribed (usually 120 kcal/kg/day is needed to demonstrate proper weight gain).
• Weigh the child daily and maintain strict records of intake and output.
• Educate parents about proper feeding techniques and volumes.
• Provide extensive support to alleviate parental anxiety related to the child’s inability to gain weight.
Adapted from Kirkland, R. T., Motil, K. J., & Duryea, T. K. (2015b). Failure to thrive (undernutrition) in children younger than two years: Management. Retrieved from http://www.uptodate.com/contents/failure-to-thrive-undernutrition-in-children-younger-than-two-years-management
Significant FTT may require hospitalization for evaluation and management. Sometimes, enteral tube feedings are necessary in order for children with FTT or feeding disorders to demonstrate adequate growth. Box 34.4 lists nursing interventions for the hospitalized child with FTT.
10)Clotting/Disseminated Intravascular Coagulation (DIC)/Cause
Brunner Ch 33 Pg 930
Pathophysiology
In DIC, normal hemostatic mechanisms are altered. The inflammatory response generated by the underlying disease initiates the process of inflammation and coagulation within the vasculature. The natural anticoagulant pathways within the body are simultaneously impaired, and the fibrinolytic system is suppressed so that a massive amount of tiny clots forms in the microcirculation. Initially, the coagulation time is normal. However, as the platelets and clotting factors form microthrombi, coagulation fails. Thus, the paradoxical result of excessive clotting is bleeding (Fig. 33-7).
The clinical manifestations of DIC are primarily reflected in compromised organ function or failure. Decline in organ function is usually a result of excessive clot formation (with resultant ischemia to all or part of the organ) or, less often, of bleeding. The excessive clotting triggers the fibrinolytic system to release fibrin degradation products, which are potent anticoagulants, furthering the bleeding. The bleeding is characterized by low platelet and fibrinogen levels; prolonged PT, aPTT, and thrombin time; and elevated fibrin degradation products and D-dimers.
The mortality rate can exceed 80% in patients who develop severe DIC with ischemic thrombosis, frank hemorrhage, and multiple organ dysfunction syndrome (MODS). Identification of patients who are at risk for DIC and recognition of the early clinical manifestations of this syndrome can result in prompt medical intervention, which may improve the prognosis. However, the primary prognostic factor is the ability to treat the underlying condition that precipitated DIC.
An intensive care nurse is aware of the need to identify patients who may be at risk of
developing disseminated intravascular coagulation (DIC). Which of the following ICU
patients most likely faces the highest risk of DIC?
A)A patient with extensive burns
B)A patient who has a diagnosis of acute respiratory distress syndrome
C)A patient who suffered multiple trauma in a workplace accident
D)A patient who is being treated for septic shock
Ans:D
Feedback:Sepsis is a common cause of DIC. A wide variety of acute illnesses can precipitate
DIC, but sepsis is specifically identified as a cause.
A patient is being treated for DIC and the nurse has prioritized the nursing diagnosis of
Risk for Deficient Fluid Volume Related to Bleeding. How can the nurse best
determine if goals of care relating to this diagnosis are being met?
A)Assess for edema.
B)Assess skin integrity frequently.
C)Assess the patient's level of consciousness frequently.
D)Closely monitor intake and output.
Ans:D
Feedback:
The patient with DIC is at a high risk of deficient fluid volume. The nurse can best
gauge the effectiveness of care by closely monitoring the patient's intake and output.
11) Clotting/ Disseminated Intravascular Coagulation (DIC)/Signs and Symptoms
Excessive bleeding
– Range from red dots and bruising to heavy bleeding from body openings or surgical incisions
• Organ damage
– Symptoms depend on organ involved ie SOB with lung involvement, stroke etc
• Shock
– Severe cases
• Chronic DIC
– Body is able to compensate
o Asymptomatic
o Minimal bleeding from skin or mouth
DIC PwrPt
Patients with frank DIC may bleed from mucous membranes, venipuncture sites, and the GI and urinary tracts. The bleeding can range from minimal occult internal bleeding to profuse hemorrhage from all orifices. Patients typically develop MODS, and they may exhibit renal failure as well as pulmonary and multifocal central nervous system infarctions as a result ofmicrothromboses, macrothromboses, or hemorrhages. During the initial process of DIC, the patient may have no new symptoms—the only manifestation being a progressive decrease in the platelet count. As the thrombosis becomes more extensive, the patient exhibits signs and symptoms of thrombosis in the organs involved. Then, as the clotting factors and platelets are consumed to form these thrombi, bleeding occurs. Initially, the bleeding is subtle, but it can develop into frank hemorrhage.
CHART 33-10: Assessing for Thrombosis and Bleeding in Disseminated Intravascular Coagulation
System Signs and Symptoms of Microvascular Thrombosis Signs and Symptoms of Microvascular and Frank Bleeding
Integumentary (skin) ↓ Temperature, sensation; ↑ pain; cyanosis in extremities, nose, earlobes; focal ischemia, superficial gangrene Petechiae, including periorbital and oral mucosa; bleeding: gums, oozing from wounds, previous injection sites, around catheters (IVs, tracheostomies); epistaxis; diffuse ecchymoses; subcutaneous hemorrhage; joint pain
Circulatory ↓ Pulses; capillary filling time >3 s Tachycardia
Respiratory Hypoxia (secondary to clot in lung); dyspnea; chest pain with deep inspiration; ↓ breath sounds over areas of large embolism High-pitched bronchial breath sounds; tachypnea; ↑ consolidation; signs and symptoms of acute respiratory distress syndrome
Gastrointestinal Gastric pain; “heartburn” Hematemesis (heme⊕ nasogastric output); melena (heme⊕ stools → tarry stools → bright-red blood from rectum); retroperitoneal bleeding (abdomen firm and tender to palpation; distended; ↑ abdominal girth)
Renal ↓ Urine output; ↑ creatinine, ↑ blood urea nitrogen Hematuria
Neurologic ↓ Alertness and orientation; ↓ pupillary reaction; ↓ response to commands; ↓ strength and movement ability Anxiety; restlessness; ↓ mentation, altered level of consciousness; headache; visual disturbances; conjunctival hemorrhage
*heme⊕, positive for hemoglobin.
Note: Signs of microvascular thrombosis are the result of an inappropriate activation of the coagulation system, causing thrombotic occlusion of small vessels within all body organs. As the clotting factors and platelets are consumed, signs of microvascular bleeding appear. This bleeding can quickly extend into frank hemorrhage. Treatment must be aimed at the disorder underlying the disseminated intravascular coagulation; otherwise, the stimulus for the syndrome will persist.
12) Clotting/ Disseminated Intravascular Coagulation (DIC)/ Diagnostic Test Results
Different tests over several days
– D-Dimer test – elevated
– Prothrombin time (PT/INR) – prolonged
– Fibrinogen – reduced
– Complete Blood Count (CBC) – low platelets
– Blood smear – damaged/abnormal cells
DIC PwrPt
Clinically, the diagnosis of DIC is often established by laboratory tests that reflect consumption of platelets and clotting factors (i.e., drop in platelet count, an elevation in fibrin degradation products and D-dimer, an increase in PT and aPTT, and a low fibrinogen level) (Table 33-4). Although each of these tests is useful in establishing the diagnosis of DIC, the specificity of each individual parameter is not great, although D-dimer levels are more accurate than fibrin degradation products. The International Society on Thrombosis and Haemostasis has developed a highly sensitive and specific scoring system using the platelet count, fibrin degradation products, PT, and fibrinogen level to diagnose DIC (Levi &Meijers, 2011) (Table 33-5). This system is also useful in predicting the severity of the disease over time and subsequent mortality
TABLE 33-4 Laboratory Values Commonly Found in Disseminated Intravascular Coagulation*
Test Function evaluated Normal Range Changes in DIC
Platelet count Platelet number 150,000–450,000/mm3 ↓
Prothrombin time (PT) Extrinsic pathway 11–12.5 seconds ↑
Partial thromboplastin time (activated)(aPTT) Intrinsic pathway 23–35 seconds ↑
Thrombin time (TT) Clot formation 8–11 seconds ↑
Fibrinogen Amount available for coagulation 170–340 mg/dL ↓
D-dimer Local fibrinolysis 0–250 ng/mL ↑
Fibrin degradation products (FDPs) Fibrinolysis 0–5 mcg/mL ↑
Euglobulin clot lysis Fibrinolytic activity ≥2 h ≤1h
DIC, disseminated intravascular coagulation; ↓, decreased; ↑, increased.
*Because DIC is a dynamic condition, the laboratory values measured will change over time. Therefore, a progressive increase or decrease in a given laboratory value is likely to be more important than the actual value of a test at a single point in time.
TABLE 33-5 Scoring System for Disseminated Intravascular Coagulation
Laboratory Test 0 1 2 3
Platelet count <100,000/mm3 <50,000/mm3, >100,000/mm >50,000/mm3
Fibrin degradation products No increase Moderate increase Strong increase
Prothrombin time (upper limit of normal) <3 seconds >3 seconds, <6 seconds >6 seconds
Fibrinogen <100 mg/dL >100 mg/dL
Note: 5 or more is compatible with overt disseminated intravascular coagulation.
Brunner- pg. 930-931
An intensive care nurse is aware of the need to identify patients who may be at risk of
developing disseminated intravascular coagulation (DIC). Which of the following ICU
patients most likely faces the highest risk of DIC?
A)A patient with extensive burns
B)A patient who has a diagnosis of acute respiratory distress syndrome
C)A patient who suffered multiple trauma in a workplace accident
D)A patient who is being treated for septic shock
Ans:D
Feedback:
Sepsis is a common cause of DIC. A wide variety of acute illnesses can precipitate
DIC, but sepsis is specifically identified as a cause.
A patient is being treated for DIC and the nurse has prioritized the nursing diagnosis of
Risk for Deficient Fluid Volume Related to Bleeding. How can the nurse best
determine if goals of care relating to this diagnosis are being met?
A)Assess for edema.
B)Assess skin integrity frequently.
C)Assess the patient's level of consciousness frequently.
D)Closely monitor intake and output.
Ans:D
Feedback:
The patient with DIC is at a high risk of deficient fluid volume. The nurse can best gauge the effectiveness of care by closely monitoring the patient's intake and output. Each of the other assessments is a necessary element of care, but none addresses fluid balance as directly as close monitoring of intake and output
13) Clotting/ITP/Treatment
The primary goal of treatment is a “safe” platelet count (i.e., platelets adequate to maintain hemostasis). Because the risk of bleeding typically does not increase until the platelet count is less than 30,000/mm3, a patient whose count exceeds 30,000/mm3 to 50,000/mm3 may be carefully observed without additional intervention. However, if the count is less than 30,000/mm3 or if bleeding occurs, the goal is to improve the patient’s platelet count rather than to cure the disease. The decision to treat should not be made merely on the basis of the patient’s platelet count but, more importantly, on the severity of bleeding (if any), likely treatment-related side effects, and the patient’s lifestyle, activity level, and overall preference. A person with a sedentary lifestyle can tolerate a low platelet count more safely than one with a more active lifestyle; however, increasing age is also associated with increased bleeding risk.
Treatment for ITP usually involves several approaches. If the patient is taking a medication known to be associated with ITP (e.g., quinine, sulfa-containing medications), then that medication must be stopped immediately. The mainstay of short-term therapy is the use of immunosuppressive agents. These agents block the binding receptors on macrophages so that the platelets are not destroyed. The American Society of Hematology recommends administering the corticosteroid prednisone at a dose of 1 mg per kilogram of body weight for 21 days and then tapering the dose until the patient is off the medication. Because of the associated side effects, patients cannot take high doses of corticosteroids indefinitely. Platelet counts typically begin to rise within a few days after institution of corticosteroid therapy. The platelet count tends to drop once the corticosteroid dose is tapered, but it often can remain at an adequate level. The immunosuppressant azathioprine (Imuran) may also be indicated, particularly when some form of “maintenance” therapy is needed to maintain the platelet count. The rise in platelet counts is slower with azathioprine. IVIG is also commonly used to treat ITP. It is effective in binding the receptors on the macrophages; however, high doses are required, the drug is very expensive, and the effect is transient. Splenectomy is an alternative treatment and results in a sustained normal platelet count approximately 50% of the time, although many patients can maintain a “safe” platelet count of more than 30,000/mm3 after removal of the spleen. Even those who do respond to splenectomy may have recurrences of severe thrombocytopenia months or years later. Patients who have undergone splenectomy are permanently at risk for sepsis and should receive pneumococcal (Pneumovax), Haemophilus influenzae type B, and meningococcal vaccines, preferably 2 to 3 weeks before the splenectomy is performed. The pneumococcal vaccine should be repeated at intervals of 5 to 10 years. Other management options include certain monoclonal antibodies (e.g., rituximab). This agent may increase platelet counts for up to 1 year in 20% to 35% of those treated, but when that response is lost, the platelet count may not fall so low as to warrant additional therapy. Infrequently, the chemotherapy agent vincristine (Oncovin) is used. Vincristine appears to work by blocking the receptors on the macrophages and therefore inhibiting platelet destruction; it may also stimulate thrombopoiesis. Another approach to the management of chronic ITP involves the use of anti-D (WinRho) in patients who are Rh (D) positive. The actual mechanism of action is unknown. One theory is that the anti-D binds to the patient’s erythrocytes, which are in turn destroyed by the body’s macrophages. The receptors in the RES may become saturated with the sensitized erythrocytes, diminishing removal of antibody-coated platelets. Anti-D produces a transient decreased hematocrit and increased platelet count in many, but not all, patients with ITP. Anti-D appears to be most effective in children with ITP and least effective in patients who have undergone splenectomy. In addition, two thrombopoietin receptor agonists have been approved for use in steroid-refractory ITP. Romiplostim (Nplate) is administered weekly as a subcutaneous injection; eltrombopag (Promacta) is given orally. The timing of taking eltrombopag is somewhat complex, as the drug metabolism is altered with food and many medications. Side effects include headache, blistering of the oral mucosa, and ecchymoses. If either of these drugs is tapered, a rebound thrombocytopenia can occur; thus, careful monitoring and plans to resume or start alternative therapy should be established. Despite extremely low platelet counts, platelet transfusions are usually avoided. Transfusions tend to be ineffective because the patient’s antiplatelet antibodies bind with the transfused platelets, causing them to be destroyed. Platelet counts can actually drop further after platelet transfusion. Occasionally, transfusion of platelets may protect against catastrophic bleeding in patients with severe wet purpura. Aminocaproic acid—a fibrinolytic enzyme inhibitor that slows the dissolution of clots—may be useful for patients with significant mucosal bleeding refractory to other treatments.
Brunner- pg. 923
A nurse is admitting a patient with immune thrombocytopenic purpura to
the unit. In completing the admission assessment, the nurse must be alert for what medications that
potentially alter platelet function? Select all that apply.
A)Antihypertensives
B)Penicillins
C)Sulfa-containing medications
D)Aspirin-based drugs
E)NSAIDs
Ans:C, D, E
Feedback:
The nurse must be alert for sulfa- containing medications and others that alter platelet
function (e.g., aspirin-based or other NSAIDs). Antihypertensive drugs and the
penicillins do not alter platelet function.
****The results of a patient's most recent blood work and physical assessment are
suggestive of immune thrombocytopenic purpura (ITP). This patient should undergo
testing for which of the following potential causes? Select all that apply.
A)Hepatitis
B)Acute renal failure
C)HIV
D)Malignant melanoma
E)Cholecystitis
Ans:A, C
Feedback: Viral illnesses have the potential to cause ITP.
A patient with a recent diagnosis of ITP has asked the nurse why the care team has not
chosen to administer platelets, stating, “I have low platelets, so why not give me a transfusion of exactly what I'm missing?” How should the nurse best respond?
A)“Transfused platelets usually aren't beneficial because they're rapidly destroyed in the body.”
B)“A platelet transfusion often blunts your body's own production of platelets even Further.”
C)“Finding a matching donor for a platelet transfusion is exceedingly difficult.”
D)“A very small percentage of the platelets in a transfusion are actually functional.”
Ans:A
Feedback:Despite extremely low platelet counts, platelet transfusions are usually avoided.
14) Clotting/ITP/Clinical Manifestations
Many patients have no symptoms, and the low platelet count is an incidental finding (often less than 30,000/mm3; less than 5,000/mm3 is not uncommon). Common physical manifestations are easy bruising, heavy menses, and petechiae on the extremities or trunk. Patients with simple bruising or petechiae (“dry purpura”) tend to have fewer complications from bleeding than those with bleeding from mucosal surfaces, such as the GI tract (including the mouth) and pulmonary system (e.g., hemoptysis), which is termed wet purpura. Patients with wet purpura have a greater risk of intracranial bleeding than do those with dry purpura. Despite low platelet counts, the platelets are young and very functional. They adhere to endothelial surfaces and to one another, so spontaneous bleeding does not always occur. Thus, treatment may not be initiated unless bleeding becomes severe or life threatening, or the platelet count is extremely low (less than 30,000/mm3).
Brunner- pg. 923
A nurse is admitting a patient with immune thrombocytopenic purpura to
the unit. In completing the admission assessment, the nurse must be alert for what medications that potentially alter platelet function? Select all that apply.
A)Antihypertensives
B)Penicillins
C)Sulfa-containing medications
D)Aspirin-based drugs
E)NSAIDs
Ans:C, D, E
Feedback:
The nurse must be alert for sulfa-containing medications and others that alter platelet
function (e.g., aspirin-based or other NSAIDs). Antihypertensive drugs and the
penicillins do not alter platelet function.
****The results of a patient's most recent blood work and physical assessment are
suggestive of immune thrombocytopenic purpura (ITP). This patient should undergo
testing for which of the following potential causes? Select all that apply.
A)Hepatitis
B)Acute renal failure
C)HIV
D)Malignant melanoma
E)Cholecystitis
Ans:A, C
Feedback:Viral illnesses have the potential to cause ITP.
A patient with a recent diagnosis of ITP has asked the nurse why the care team has not
chosen to administer platelets, stating, “I have low platelets, so why not give me a
transfusion of exactly what I'm missing?” How should the nurse best respond?
A)“Transfused platelets usually aren't beneficial because they're rapidly destroyed in the body.”
B)“A platelet transfusion often blunts your body's own production of platelets even
further.”
C)“Finding a matching donor for a platelet transfusion is exceedingly difficult.”
D)“A very small percentage of the platelets in a transfusion are actually functional.”
Ans:A
Feedback: Despite extremely low platelet counts, platelet transfusions are usually avoided.
15) Clotting/ITP/Nursing care
Nursing care includes an assessment of the patient’s lifestyle to determine the risk of bleeding from activity. A careful medication history is also obtained, including use of overthe-counter medications, herbs, and nutritional supplements. The nurse must be alert for sulfa-containing medications and others that alter platelet function (e.g., aspirin-based or other NSAIDs). The nurse assesses for any history of recent viral illness and reports of headache or visual disturbances, which could be initial symptoms of intracranial bleeding. Patients who are admitted to the hospital with wet purpura and low platelet counts should have a neurologic assessment incorporated into their routine vital sign measurements. All injections or rectal medications should be avoided, and rectal temperature measurements should not be performed, because they can stimulate bleeding. Studies of patients with ITP have demonstrated a significant increase in fatigue compared to those without the disease that was not associated with the duration of the disease, corticosteroid use, bleeding episodes, and low platelet count. Nurses should explore the extent the patient experiences fatigue and offer strategies to ameliorate this problem. Patient education addresses signs of exacerbation of disease (e.g., petechiae, ecchymoses), how to contact appropriate health care personnel, the name and type of medication inducing ITP (if appropriate), current medical treatment (medications, side effects, tapering schedule if relevant), and the frequency of monitoring the platelet count. The patient is instructed to avoid all agents that interfere with platelet function, including herbal therapies and over-the-counter medications. The patient should avoid constipation, the Valsalva maneuver (e.g., straining at stool), and vigorous flossing of the teeth. Electric razors should be used for shaving, and soft-bristled toothbrushes should replace stiff-bristled ones. The patient may also be counseled to refrain from vigorous sexual intercourse when the platelet count is less than 10,000/mm3. Patients who are receiving corticosteroids long term are at risk for complications including osteoporosis, proximal muscle wasting, cataract formation, and dental caries (cavities). Bone mineral density should be monitored, and these patients may benefit from calcium and vitamin D supplementation and bisphosphonate therapy to prevent significant bone disease.
Brunner- pg. 924
Osteoporosis with vertebral compression fractures, pathologic fractures of long bones, aseptic Encourage diet high in calcium and vitamin D or calcium and vitamin D supplementation if indicated.
Take measures to avoid falls and other trauma.
Use caution in moving and turning patient.
Encourage postmenopausal women on corticosteroids to consider bone mineral density testing and treatment, if indicated.
Instruct patient to rise slowly from bed or chair to avoid falling due to postural hypotension
Muscle wasting Encourage high protein intake.
Glaucoma Encourage yearly eye examinations.
Brunner- pg. 1502
16)
Clotting/HELLP/Clinical Manifestations
Pathophysiology
The hemolysis that occurs is termed microangiopathic hemolytic anemia. This cascade of events is thought to happen when RBCs become fragmented as they pass through small, damaged blood vessels. Elevated liver enzymes are the result of reduced blood flow to the liver secondary to obstruction from fibrin deposits. At the same time, endothelial damage and fibrin deposition in the liver may lead to liver impairment and can result in hemorrhagic necrosis, indicated by right upper quadrant (RUQ) tenderness, nausea, and vomiting. Hyperbilirubinemia and jaundice result from liver impairment. Low platelets result from vascular damage, the result of vasospasm, and platelets aggregate at sites of damage, resulting in thrombocytopenia in multiple sites
(Ricci 657)Ricci, Susan. Maternity and Pediatric Nursing, 2nd Edition. Wolters Kluwer Health, 11/2012. VitalBook file.
17) Clotting/HELLP/Diagnostic Values
A diagnosis of HELLP syndrome is made based on laboratory test results, including:
• Low hematocrit that is not explained by any blood loss
• Elevated LDH (liver impairment)
• Elevated AST (liver impairment)
• Elevated ALT (liver impairment)
• Elevated BUN
• Elevated bilirubin level
• Elevated uric acid and creatinine levels (renal involvement)
• Low platelet count (less than 100,000 cells/mm3)
(Ricci 657 Ricci, Susan
.Platelets 150,000–350,000/mm3 No significant change
Hematocrit, PCV, % 37–47 32–42
Blood urea nitrogen (BUN), mg/dL 20–25 Decreases
Bilirubin total Not more than 1 mg/dL Unchanged
(Ricci 1957)
Serum uric acid, mg/kg/24 hr 257–750 Decreases
(Ricci 1958)
Serum creatinine, mg/kg/24 hr 20–22 Decreases
(Ricci 1958)
Ricci, Susan. Maternity and Pediatric Nursing, 2nd Edition. Wolters Kluwer Health, 11/2012. VitalBook file.
The citation provided is a guideline. Please check each citation for accuracy before use.
the first row of numbers is for a women who is not pregnant and the second row is for a pregnant woman. The hepatic values are nonexistent in Ricci
18) Clotting/HELLP/Therapeutic Management
Therapeutic Management
The treatment for HELLP syndrome is based on the severity of the disease, the gestational age of the fetus, and the condition of the mother and fetus. The mainstay of treatment is lowering of high blood pressure with rapid-acting antihypertensive agents, prevention of convulsions or further seizures with magnesium sulfate, and use of steroids for fetal lung maturity if necessary, followed by the birth of the infant . The client should be admitted or transferred to a tertiary center with a neonatal intensive care unit. Additional treatment includes correction of the coagulopathies that accompany HELLP syndrome. After this syndrome is diagnosed and the woman’s condition is stable, birth of the infant is indicated.
Magnesium sulfate is used prophylactically to prevent seizures. Antihypertensives such as hydralazine or labetalol are given to control blood pressure. Blood component therapy—fresh-frozen plasma, packed red blood cells, or platelets—is transfused to address the microangiopathic hemolytic anemia. Birth may be delayed up to 96 hours so that betamethasone or dexamethasone can be given to stimulate lung maturation in the preterm fetus.
(Ricci 657) Ricci, Susan. Maternity and Pediatric Nursing, 2nd Edition. Wolters Kluwer Health, 11/2012. VitalBook file.
19) Clotting/Heparin Induced Thrombocytopenia/ Medical Management
anticoagulants cannot dissolve a thrombus that has already formed. Combining anticoagulation therapy with mechanical and ultrasonic-assisted thrombolytic therapy may eliminate venous obstruction, maintain venous patency, and prevent postthrombotic syndrome by early removal of the thrombus (Hinkle 847)
Treatment for HIT includes prompt cessation of heparin (including any heparin-coated catheters) and initiation of an alternative means of anticoagulation. If the heparin is stopped without providing additional anticoagulation, the patient is at increased risk for developing new thrombi. Two inhibitors of thrombin—lepirudin (Refludan) and argatroban—are FDA-approved anticoagulants for the treatment of HIT. Oral anticoagulation with warfarin is contraindicated because it initially promotes thrombosis in the microvasculature by depleting protein C, which can lead to ischemia and gangrenous limbs . Once the platelet count has recovered, transitioning to treatment with warfarin is possible. Individuals who develop thrombosis in the setting of HIT should receive anticoagulation for 3 to 6 months; the duration of anticoagulation in the absence of thrombosis is less well studied . Patients need to be aware of their risk for reactivation of the disorder should they be exposed to any amount of heparin within 3 to 4 months after diagnosis. This time frame is thought to be sufficient to remove anti-heparin platelet antibodies from the circulation by the RES. (Hinkle 936-937)
21) Clotting/Blood transfusion/Process
CHART 32-2
Transfusion of Packed Red Blood Cells
Preprocedure
1. Confirm that the transfusion has been prescribed.
2. Check that patient’s blood has been typed and crossmatched.
3. Verify that patient has signed a written consent form per institution or agency policy and agrees to procedure.
4. Explain procedure to patient. Instruct patient in signs and symptoms of transfusion reaction (itching, hives, swelling, shortness of breath, fever, chills).
5. Take patient’s temperature, pulse, respiration, and blood pressure to establish a baseline and auscultate lungs; assess for jugular venous distention to serve as a baseline for comparison during transfusion.
6. Use hand hygiene and wear gloves in accordance with standard precautions.
7. Use a 20-gauge or larger needle for insertion in a large vein. Use special tubing that contains a blood filter to screen out fibrin clots and other particulate matter. Do not vent blood container.
Procedure
1. Obtain packed red blood cells (PRBCs) from the blood bank after the IV line is started. (Institution policy may limit release to only 1 unit at a time.)
2. Double-check labels with another nurse or physician to ensure that the ABO group and Rh type agree with the compatibility record. Check to see that number and type on donor blood label and on patient’s medical record are correct. Confirm patient’s identification by asking the patient’s name and checking the identification wristband.
3. Check blood for gas bubbles and any unusual color or cloudiness. (Gas bubbles may indicate bacterial growth. Abnormal color or cloudiness may be a sign of hemolysis.)
4. Make sure that PRBC transfusion is initiated within 30 minutes after removal of the PRBCs from blood bank refrigerator.
5. For first 15 minutes, run the transfusion slowly—no faster than 5 mL/min. Observe patient carefully for adverse effects. If no adverse effects occur during the first 15 minutes, increase the flow rate unless patient is at high risk for circulatory overload.
6. Monitor closely for 15–30 minutes to detect signs of reaction. Monitor vital signs at regular intervals per institution or agency policy; compare results with baseline measurements. Increase frequency of measurements based on patient’s condition. Observe patient frequently throughout the transfusion for any signs of adverse reaction, including restlessness, hives, nausea, vomiting, torso or back pain, shortness of breath, flushing, hematuria, fever, or chills. Should any adverse reaction occur, stop infusion immediately, notify primary provider, and follow the agency’s transfusion reaction standard.
7. Note that administration time does not exceed 4 hours because of increased risk of bacterial proliferation.
8. Be alert for signs of adverse reactions: circulatory overload, sepsis, febrile reaction, allergic reaction, and acute hemolytic reaction.
9. Change blood tubing after every 2 units transfused to decrease chance of bacterial contamination.
Postprocedure
1. Obtain vital signs and compare with baseline measurements.
2. Dispose of used materials properly.
3. Document procedure in patient’s medical record, including patient assessment findings and tolerance to procedure.
4. Monitor patient for response to and effectiveness of procedure.
Note: Never add medications to blood or blood products; if blood is too thick to run freely, normal saline may be added to the unit. If blood must be warmed, use an in-line blood warmer with a monitoring system.
(Hinkle 892)
Hinkle, Janice L., Kerry Cheever. Hinkle & Cheever: Brunner &Suddarth's Textbook of Medical-Surgical Nursing, 13th Edition. CoursePoint, 11/2013. VitalBook file.
22) Clotting/Blood transfusion/Transfusion Reaction
Patient Education
Reviewing the signs and symptoms of a transfusion reaction is crucial for patients who have not received a previous transfusion. Even for patients who have received prior transfusions, a brief review of the signs and symptoms of transfusion reactions is advised. Signs and symptoms of a reaction include fever, chills, respiratory distress, low back pain, nausea, pain at the IV site, or anything “unusual.” Although a thorough review is very important, the nurse also reassures the patient that the blood is carefully tested against the patient’s own blood (cross-matched) to diminish the likelihood of any untoward reaction. Similarly, the patient can be reassured about the very low possibility of contracting HIV from the transfusion; this fear persists among many people.
Complications
Any patient who receives a blood transfusion is at risk for developing complications from the transfusion. During patient education, the nurse explains the risks and benefits and what to expect during and after the transfusion. Patients must be informed that although it has been tested carefully, the supply of blood is not completely risk free. Nursing management is directed toward preventing complications, promptly recognizing complications if they develop, and promptly initiating measures to control complications. The following sections describe the most common or potentially severe transfusion-related complications.
Febrile Nonhemolytic Reaction
A febrile nonhemolytic reaction is caused by antibodies to donor leukocytes that remain in the unit of blood or blood component; it is the most common type of transfusion reaction. It occurs more frequently in patients who have had previous transfusions (exposure to multiple antigens from previous blood products) and in Rh-negative women who have borne Rh-positive children (exposure to an Rh-positive fetus raises antibody levels in the untreated mother).
The diagnosis of a febrile nonhemolytic reaction is made by excluding other potential causes, such as a hemolytic reaction or bacterial contamination of the blood product. The signs and symptoms of a febrile nonhemolytic transfusion reaction are chills (minimal to severe) followed by fever (more than 1 °C elevation). The fever typically begins within 2 hours after the transfusion is begun. Although the reaction is not life threatening, the fever, and particularly the chills and muscle stiffness, can be frightening to the patient.
This reaction can be diminished, even prevented, by further depleting the blood component of donor leukocytes; this is accomplished by a leukocyte reduction filter. Antipyretic agents can be given to prevent fever; however, routine premedication is not advised because it can mask the beginning of a more serious transfusion reaction.
Acute Hemolytic Reaction
The most dangerous, and potentially life-threatening, type of transfusion reaction occurs when the donor blood is incompatible with that of the recipient (i.e., type II hypersensitivity reaction). Antibodies already present in the recipient’s plasma rapidly combine with antigens on donor erythrocytes, and the erythrocytes are destroyed in the circulation (i.e., intravascular hemolysis). The most rapid hemolysis occurs in ABO incompatibility. Rh incompatibility often causes a less severe reaction. This reaction can occur after transfusion of as little as 10 mL of PRBCs. Although the overall incidence of such reactions is not high (1:20,000 to 1:40,000 units transfused [Leo & Pedal, 2010]), they are largely preventable. The most common causes of acute hemolytic reaction are errors in blood component labeling and patient identification that result in the administration of an ABO-incompatible transfusion.
Symptoms consist of fever, chills, low back pain, nausea, chest tightness, dyspnea, and anxiety. As the erythrocytes are destroyed, the hemoglobin is released from the cells and excreted by the kidneys; therefore, hemoglobin appears in the urine (hemoglobinuria). Hypotension, bronchospasm, and vascular collapse may result. Diminished renal perfusion results in acute renal failure, and disseminated intravascular coagulation may also occur. The reaction must be recognized promptly and the transfusion discontinued immediately (see the Nursing Management for Transfusion Reactions section).
Acute hemolytic transfusion reactions are preventable. Meticulous attention to detail in labeling blood samples and blood components and accurately identifying the recipient cannot be overemphasized. Bar coding methods can be useful safeguards in matching a patient’s wristband with the label on the blood component (Pagliaro, Turdo, &Capuzzo, 2009); however, these methods are not fail proof and do not reduce the nurse’s responsibility to ensure the correct blood component is transfused to the correct patient.
Allergic Reaction
Some patients develop urticaria (hives) or generalized itching during a transfusion; the cause is thought to be a sensitivity reaction to a plasma protein within the blood component being transfused. Symptoms of an allergic reaction are urticaria, itching, and flushing. The reactions are usually mild and respond to antihistamines. If the symptoms resolve after administration of an antihistamine (e.g., diphenhydramine [Benadryl]), the transfusion may be resumed. Rarely, the allergic reaction is severe, with bronchospasm, laryngeal edema, and shock. These reactions are managed with epinephrine, corticosteroids, and vasopressor support, if necessary.
Giving the patient antihistamines or corticosteroids before the transfusion may prevent future reactions. For severe reactions, future blood components are washed to remove any remaining plasma proteins. Leukocyte filters are not useful to prevent such reactions, because the offending plasma proteins can pass through the filter.
Circulatory Overload
If too much blood is infused too quickly, hypervolemia can occur. This condition can be aggravated in patients who already have increased circulatory volume (e.g., those with heart failure). PRBCs are safer to use than whole blood. If the administration rate is sufficiently slow, circulatory overload may be prevented. For patients who are at risk for, or already in, circulatory overload, diuretics are administered after the transfusion or between units of PRBCs. Patients receiving fresh-frozen plasma or even platelets may also develop circulatory overload. The infusion rate of these blood components must also be titrated to the patient’s tolerance.
Signs of circulatory overload include dyspnea, orthopnea, tachycardia, and sudden anxiety. Jugular vein distention, crackles at the base of the lungs, and an increase in blood pressure can also occur. If the transfusion is continued, pulmonary edema can develop, as manifested by severe dyspnea and coughing of pink, frothy sputum.
If fluid overload is mild, the transfusion can often be continued after slowing the rate of infusion and administering diuretics. However, if the overload is severe, the patient is placed upright with the feet in a dependent position, the transfusion is discontinued, and the primary provider is notified. The IV line is kept patent with a very slow infusion of normal saline solution or a saline lock device to maintain access to the vein in case IV medications are necessary. Oxygen and morphine may be needed to treat severe dyspnea (see Chapter 29).
Bacterial Contamination
The incidence of bacterial contamination of blood components is very low; however, administration of contaminated products puts the patient at great risk. Contamination can occur at any point during procurement or processing but often results from organisms on the donor’s skin. Many bacteria cannot survive in the cold temperatures used to store PRBCs, but some organisms can do so. Platelets are at greater risk of contamination because they are stored at room temperature. Recently, blood centers have developed rapid methods of culturing platelet units, thereby diminishing the risk of using a contaminated platelet unit for transfusion.
Preventive measures include meticulous care in the procurement and processing of blood components. When PRBCs or whole blood is transfused, it should be administered within a 4-hour period, because warm room temperatures promote bacterial growth. A contaminated unit of blood product may appear normal, or it may have an abnormal color.
The signs of bacterial contamination are fever, chills, and hypotension. These manifestations may not occur until the transfusion is complete, occasionally not until several hours after the transfusion. As soon as the reaction is recognized, any remaining transfusion is discontinued (see the Nursing Management for Transfusion Reactions section). If the condition is not treated immediately with fluids and broadspectrum antibiotics, sepsis can occur. Sepsis is treated with IV fluids and antibiotics; corticosteroids and vasopressors are often also necessary (see Chapter 14).
Transfusion-Related Acute Lung Injury
Transfusion-related acute lung injury (TRALI) is a potentially fatal, idiosyncratic reaction that is defined as the development of acute lung injury occurring within 6 hours after a blood transfusion. All blood components have been implicated in TRALI, including IVIG, cryoprecipitate, and stem cells. TRALI is the most common cause of transfusion-related death (Cherry, Steciuk, Reddy, et al., 2008).
The underlying pathophysiologic mechanism for TRALI is unknown but is thought to involve antibodies in the donor’s plasma that react to the leukocytes in the recipient’s blood. Occasionally, the reverse occurs, and antibodies present in the recipient’s plasma agglutinate the antigens on the few remaining leukocytes in the blood component being transfused. Another theory suggests that an initial insult to the patient’s vascular endothelium causes neutrophils to aggregate at the injured endothelium. Various substances within the transfused blood component (lipids, cytokines) then activate these neutrophils. Each of these pathophysiologic mechanisms can contribute to the process (Fung & Silliman, 2009). The end result of this process is interstitial and intraalveolar edema, as well as extensive sequestration of WBCs within the pulmonary capillaries.
Onset is abrupt (usually within 6 hours of transfusion, often within 2 hours). Signs and symptoms include acute shortness of breath, hypoxia (arterial oxygen saturation [SaO2] less than 90%; partial pressure of arterial oxygen [PaO2] to fraction of inspired oxygen [FIO2] ratio of less than 300), hypotension, fever, and eventual pulmonary edema. Diagnostic criteria include hypoxemia, bilateral pulmonary infiltrates (seen on chest x-ray), no evidence of cardiac cause for the pulmonary edema, and no other plausible alternative cause within 6 hours of completing transfusion. Aggressive supportive therapy (e.g., oxygen, intubation, fluid support) may prevent death.
Although TRALI can occur with the transfusion of any blood component, it is more likely to occur when plasma and, to a lesser extent, platelets are transfused. One commonly used preventive strategy involves limiting the frequency and amount of blood products transfused. Another entails obtaining plasma and possibly platelets only from men or from women who have never been pregnant (and, consequently, are less likely to have developed offending antibodies). The efficacy of this approach and its impact on the availability of these blood components remain unclear (Müller, Porcelijn, &Vlaar, 2012).
Delayed Hemolytic Reaction
Delayed hemolytic reactions usually occur within 14 days after transfusion, when the level of antibody has been increased to the extent that a reaction can occur. The hemolysis of the erythrocytes is extravascular via the RES and occurs gradually.
Signs and symptoms of a delayed hemolytic reaction are fever, anemia, increased bilirubin level, decreased or absent haptoglobin, and possibly jaundice. Rarely, there is hemoglobinuria. Generally, these reactions are not dangerous, but it is important to recognize them because subsequent transfusions with blood products containing these antibodies may cause a more severe hemolytic reaction. However, recognition is also difficult because the patient may not be in a health care setting to be tested for this reaction, and even if the patient is hospitalized, the reaction may be too mild to be recognized clinically. Because the amount of antibody present can be too low to detect, it is difficult to prevent delayed hemolytic reactions. Fortunately, the reaction is usually mild and requires no intervention.
Disease Acquisition
Despite advances in donor screening and blood testing, certain diseases can still be transmitted by transfusion of blood components (Chart 32-4).
Complications of Long-Term Transfusion Therapy
The complications that have been described represent a real risk to any patient any time a blood component is administered. However, patients with long-term transfusion requirements (e.g., those with myelodysplastic syndrome, thalassemia, aplastic anemia, sickle cell anemia) are at greater risk for infection transmission and for becoming more sensitized to donor antigens, simply because they are exposed to more units of blood and, consequently, more donors. A summary of complications associated with long-term transfusion therapy is given in Table 32-5.
Iron overload is a complication unique to people who have had long-term PRBC transfusions. One unit of PRBCs contains 250 mg of iron. Patients with chronic transfusion requirements can quickly acquire more iron than they can use, leading to iron overload. Over time, the excess iron deposits in body tissues and can cause organ damage, particularly in the liver, heart, testes, and pancreas. Promptly initiating a program of iron chelation therapy can prevent end-organ damage from iron toxicity. (See Chapter 33, Hereditary Hemochromatosis, Nursing Management, and Chapter 34, Myelodysplastic Syndrome, Nursing Management.)
Brunner p.893-895
23) Clotting/Blood transfusion/Process
24) Perfusion/TOF/Laboratory findings
Note increased hematocrit, hemoglobin, and RBC count associated with polycythemia. Additional testing may include:
• Echocardiography (ultrasound study of structure and motion of heart), possibly revealing right ventricular hypertrophy, decreased pulmonary blood flow, and reduced size of the pulmonary artery
• Electrocardiogram (ECG), indicating right ventricular hypertrophy
• Cardiac catheterization and angiography, which reveal the extent of the structural defects
Ricci p. 1542
25) Perfusion/TOF/Hypercyanotic episode
Health History and Physical Examination
Obtain the health history, noting a history of color changes associated with feeding, activity, or crying. Determine if the infant or child is demonstrating hypercyanotic spells. Hypercyanosis develops suddenly and is manifested as increased cyanosis, hypoxemia, dyspnea, and agitation. If the infant’s oxygen demand is greater than the supply, such as with crying or during feeding, then the spell progresses to anoxia. When the degree of cyanosis is severe and persistent, the infant may become unresponsive. As the infant gets older, he or she may use specific postures, such as bending at the knees or assuming the fetal position, to relieve a hypercyanotic spell. The walking infant or toddler may squat periodically. These positions improve pulmonary blood flow by increasing systemic vascular resistance. Ask the parents if they have noticed any of these unusual positions. Note history of irritability, sleepiness, or difficulty breathing.
During the physical examination, observe the skin color and note any evidence of cyanosis. Also observe for changes in skin color with positional changes, andinspect the fingers for clubbing. Note if the child has a hypercyanotic spell during the assessment. Count the child’s respiratory rate and observe work of breathing, noting retractions, shortness of breath, or noisy breathing. Document oxygen saturation via pulse oximetry; it will likely be decreased. Auscultate the chest for adventitious breath sounds, which may suggest the development of heart failure. Auscultate the heart, noting a loud, harsh murmur characteristic of this disorder.
26) Perfusion/TOF/Pathophysiology
Tetralogy of Fallot
Tetralogy of Fallot is a congenital heart defect composed of four heart defects: pulmonary stenosis (a narrowing of the pulmonary valve and outflow tract, creating an obstruction of blood flow from the right ventricle to the pulmonary artery), VSD, overriding aorta (enlargement of the aortic valve to the extent that it appears to arise from the right and left ventricles rather than the anatomically correct left ventricle), and right ventricular hypertrophy (the muscle walls of the right ventricle increase in size due to continued overuse as the right ventricle attempts to overcome a high-pressure gradient). Surgical intervention is usually required during the first year of life (Brown & Fulton, 2011; Darst, Collins, & Miyamoto, 2014).
PATHOPHYSIOLOGY
With pulmonary stenosis, the blood flow from the right ventricle is obstructed and slowed, resulting in a decrease in blood flow to the lungs for oxygenation and a decrease in the amount of oxygenated blood returning to the left atrium from the lungs. The obstructed flow also increases the pressure in the right ventricle. This blood, which is poorly oxygenated, is then shunted across the VSD into the left atrium. Poorly oxygenated blood also travels through the overriding aorta (if it extends to both ventricles). In some cases when the VSD is large, the pressure in the right ventricle may be equal to that of the left ventricle. In this case, the path of blood shunting depends on which circulation is exerting the higher pressure, pulmonary or systemic.
Regardless of which way shunting occurs, a mixing of oxygenated and poorly oxygenated blood occurs, with this blood ultimately being pumped into the systemic circulation. The oxygen saturation of the blood in the systemic circulation is reduced, leading to cyanosis. The degree of cyanosis depends on the extent of the pulmonary stenosis, the size of the VSD, and the vascular resistance of the pulmonary and systemic circulations.
Tetralogy of Fallot is usually diagnosed during the first weeks of life due to the presence of a murmur and/or cyanosis.Some newborns may be acutely cyanotic, while others may exhibit only mild cyanosis that gradually becomes more severe, particularly during times of stress as the child grows older. Most often, infants with tetralogy of Fallot have a PDA at birth, providing additional pulmonary blood flow and thereby decreasing the severity of the initial cyanosis. Later, as the ductus arteriosus closes, such as within the first days of life, more severe cyanosis can occur (Fig. 41.2) (Brown & Fulton, 2011; Darst et al., 2014).
Ricci p.1539-1542
27) Perfusion/Patent Ductus Arterosus/Pathophysiology
Patent ductus arteriosus results from persistence of the fetal ductus beyond the prenatal period.78 In fetal life, the ductus arteriosus is the vital link by which blood from the right side of the heart bypasses the lungs and enters the systemic circulation (Fig. 19-21G). After birth, this passage no longer is needed, and it usually closes during the first 24 to 72 hours of life. The physiologic stimulus and mechanisms associated with permanent closure of the ductus are not entirely known, but the fact that infant hypoxia predisposes to a delayed closure suggests that the increase in arterial oxygen levels that occurs immediately after birth plays a role. Additional factors that contribute to closure are a fall in endogenous levels of prostaglandins and adenosine and the release of vasoactive substances. After constriction, the lumen of the ductus becomes permanently sealed with fibrous tissue within 2 to 3 weeks. Ductal closure may be delayed or prevented in very premature infants, probably as a result of a combination of factors, including decreased medial smooth muscle in the ductus wall, decreased vasoconstriction response to oxygen, and increased circulating levels of prostaglandins, which have a vasodilating effect. Ductal closure also may be delayed in infants with congenital heart defects that produce a decrease in oxygen tension.78 p. 476 p. 477
Persistent patency of the ductus arteriosus is defined as a duct that remains open beyond 3 months in the full-term infant. PDA is failure of the ductus arteriosus, a fetal circulatory structure, to close within the first weeks of life (Fig. 41.7). As a result, there is a connection between the aorta and pulmonary artery. PDA is the second most common congenital heart defect and accounts for 10% of CHD cases (Darst et al., 2014). PDA occurs much more frequently in premature than in term infants and in infants born at high altitudes compared with those born at sea level. Infants with other CHDs that result in right-to-left shunting of blood and cyanosis may additionally display a PDA. In these infants, the PDA allows for some level of oxygenated blood to reach the systemic circulation.
28) Perfusion/Patent Ductus Arterosus/Treatment
Although closure of a patent ductus is uniformly recommended when it is present as an isolated lesion, deliberate maintenance of ductal patency can be a lifesaving therapy for children with complex forms of congenital heart disease who have ductal-dependent pulmonary or systemic blood flow, or those with obligatory mixing of the arterial and venous circulations (i.e., transposition of the great arteries). Intravenous infusion of prostaglandin E1 (PGE1) has proved extremely effective in maintaining ductal patency or reopening the ductus in newborns. Today, this therapy is routinely administered to newborns with suspected congenital heart defects until they can be transported to a specialized center where a diagnosis can be confirmed.Spontaneous closure of the ductus seldom occurs after infancy. In the full-term infant or older child, closure can be achieved with either surgical ligation or device occlusion. In children with a small patent ductus, closure is done to prevent infective endocarditis or other complications. In children with a moderate to large patent ductus, closure is accomplished to treat heart failure, prevent the development of pulmonary vascular disease, or both.78 Drugs that inhibit prostaglandin synthesis (e.g., indomethacin) may be used to induce closure of a patent ductus in preterm newborns. Indomethacin works best if it is used in infants younger than 13 days of age; it is not effective later than 4 to 6 weeks of age.7
29) Perfusion/Patent Ductus Arterosus/Clinical manifestations
Determine the health history , which may reveal frequent respiratory infections, fatigue, and poor growth and development. On physical examination, note tachycardia, tachypnea, bounding peripheral pulses, and a widened pulse pressure. The diastolic BP typically is low due to the shunting. Auscultate the lungs and heart, noting rales if heart failure is present. Note a harsh, continuous, machine-like murmur, usually loudest under the left clavicle at the first and second intercostal spaces.The size of the persistent ductus and the difference between the systemic and pulmonary vascular resistance determine its clinical manifestations. Blood typically shunts across the ductus from the higher-pressure left side (systemic circulation) to the lower-pressure right side (pulmonary circulation). After the infant’s pulmonary vascular resistance falls, the patent ductus arteriosus provides for a continuous runoff of aortic blood into the pulmonary artery. With a large patent ductus, the runoff is continuous, resulting in increased pulmonary blood flow, pulmonary congestion, and increased resistance against which the right side of the heart must pump. Increased pulmonary venous return and increased work demands may lead to left ventricular failure.
Failure of the ductus arteriosus to close leads to continued blood flow from the aorta to the pulmonary artery. Blood returning to the left atrium passes to the left ventricle, enters the aorta, and then travels to the pulmonary artery via the PDA instead of entering the systemic circulation. This altered blood flow pattern increases the workload of the left side of the heart. Pulmonary vascular congestion occurs, causing an increase in pressure. Right ventricular pressure increases in an attempt to overcome this increase in pulmonary blood flow, pulmonary congestion, and increased resistance against which the right side of the heart must pump. Increased pulmonary venous return and increased work demands may lead to left ventricular failure.
Failure of the ductus arteriosus to close leads to continued blood flow from the aorta to the pulmonary artery. Blood returning to the left atrium passes to the left ventricle, enters the aorta, and then travels to the pulmonary artery via the PDA instead of entering the systemic circulation. This altered blood flow pattern increases the workload of the left side of the heart. Pulmonary vascular congestion occurs, causing an increase in pressure. Right ventricular pressure increases in an attempt to overcome this increase in pulmonary pressure. Eventually, right ventricular hypertrophy occurs.
30) Perfusion/Coarctation of the Aorta/Clinical Manifestations
The classic sign of coarctation of the aorta is a disparity in pulsations and blood pressures in the arms and legs. The femoral, popliteal, and dorsalis pedis pulsations are weak or delayed compared with the bounding pulses of the arms and carotid vessels.
Normally, the systolic blood pressure in the legs obtained by the cuff method is 10 to 20 mm Hg higher than in the arms. In coarctation, the pressure in the legs is lower and may be difficult to obtain. Patients with coarctation are often identified during a diagnostic workup for hypertension. Most patients with moderate coarctation remain otherwise asymptomatic owing to collateral vessels that form around the area of narrowing. Left untreated, however, coarctation will result in left ventricular hypertension and hypertrophy and significant systemic hypertension (see Chapter 18). Infants with severe coarctation demonstrate early symptoms of heart failure and may present in critical condition upon ductal closure. Reopening of the duct with prostaglandin E1, if possible, and emergent surgery are needed in this subgroup.88
Determine the health history, noting problems with irritability and frequent epistaxis. In older children, there also may be reports of leg pain with activity, dizziness, fainting, and headaches. Assess pulses throughout, noting full, bounding pulses in the upper extremities with weak or absent pulses in the lower extremities. Determine BP in all four extremities. BP in the upper extremities may be 20 mm Hg or higher than that in the lower extremities. Inspect the school-age child’s chest, noting notching of the ribs. Auscultate the heart for a soft or moderately loud systolic murmur, most often heard at the base of the heart (on the back or in the left axilla)
31) Perfusion/Coarctation of the Aorta
Coarctation of the aorta is narrowing of the aorta, the major blood vessel carrying highly oxygenated blood from the left ventricle of the heart to the rest of the body. Coarctation of the aorta consists of a localized narrowing of the aorta. It can occur proximal to (preductal) distal to (postductal), or opposite of (juxtaductal) the entry of the ductus arteriosus. Approximately 98% of coarctations are juxtaductal. The defect is frequently associated with other congenital cardiac lesions, most commonly bicuspid aortic valve, and occurs in approximately 10% of subjects with Turner syndrome, suggesting a genetic linkage. Children with coarctation causing a blood pressure gradient between the arms and legs of 20 mm Hg or greater should ideally be treated by 2 years of age to reduce the likelihood of persistent hypertension.88 A surgical approach typically involves resection of the narrowed segment of the aorta and end-to-end anastomosis of healthy tissue. This can usually be accomplished without cardiopulmonary bypass, with a mortality rate near zero. Balloon angioplasty with or without stent placement has also been used, although the presence of residual gradients and the reliability of the surgical approach have limited this technique.88
32) Perfusion/Ventricular Septal Defect/Treatments
The treatment of a ventricular septal defect depends on the size of the defect, accompanying hemodynamic derangements, and symptomatology. Children with small or medium-sized defects may be followed without intervention if they remain free from signs of congestive heart failure or pulmonary hypertension. Ventricular defects do not increase in size, and some spontaneously close over time.22 Prophylactic antibiotic therapy is given during periods of increased risk for bacteremia. The management of infants with large ventricular defects aims to control heart failure and prevent the development of pulmonary vascular disease. Symptomatic infants may require feeding supplements or tube feeding to promote growth and development. In the symptomatic infant in whom complete repair cannot be achieved because of size or other complicating lesions, a palliative procedure may be performed to reduce symptoms. Placement of a synthetic band around the main pulmonary artery (pulmonary artery banding) can reduce pulmonary blood flow until complete repair can be accomplished. Surgical closure of the defect is completed by placement of a synthetic or autologous patch effectively to close the shunt across the ventricular septum. These procedures are typically done electively in the infant or young child and are associated with low morbidity and mortality rates.
33) Perfusion/Ventricular Septal Defect/
Ventricular Septal Defect
A VSD is an opening between the right and left ventricular chambers of the heart (Fig. 41.5). It is one of the most common congenital heart defects and accounts for about 30% of all congenital heart defects. Spontaneous closure of small VSDs occurs in about half of children by age 2 years. Long-term outcomes for surgically repaired VSDs are good. Repair of larger defects by 2 years of age is recommended to prevent the development of pulmonary disease (Brown & Fulton, 2011;Darst et al., 2014).
FIGURE 41.5. Ventricular septal defect; note the opening between the ventricles.
Pathophysiology
In VSD, there is an abnormal opening between the right and left ventricles. The opening varies in size, from as small as a pinhole to a complete opening between the ventricles so that the right and left sides are as one. Children with small VSDs may remain asymptomatic. In other children, blood shunts across the opening in the septum. Pulmonary vascular resistance and systemic vascular resistance determine the direction of blood flow. A left-to-right shunt results when pulmonary vascular resistance is low. Increased amounts of blood flowing into the right ventricle are then pumped to the pulmonary circulation, eventually causing an increase in pulmonary vascular resistance. Increased pulmonary vascular resistance leads to increased pulmonary artery pressure (pulmonary hypertension) and right ventricular hypertrophy. When the pulmonary vascular resistance exceeds the systemic vascular resistance, right-to-left shunting of blood across the VSD occurs, resulting in Eisenmenger syndrome (pulmonary hypertension and cyanosis). Heart failure commonly occurs in children with moderate to severe unrepaired VSDs. Children with VSDs are also at risk for the development of aortic valve regurgitation as well as infective endocarditis (Brown & Fulton, 2011;Darst et al., 2014).
Nursing Assessment
Initially, the newborn may not exhibit any signs and symptoms at birth because left-to-right shunting is most likely minimal due to the high pulmonary resistance common after birth.
Health History and Physical Examination
Determine the health history, which commonly reveals signs of heart failure around 4 to 8 weeks of age. Note history of tiring easily, particularly with exertion or feeding. Document the child’s growth history, noting difficulty thriving. Ask the parent about color change or diaphoresis with nipple feeding in the infant. Note history of frequent pulmonary infections, shortness of breath, and possibly edema. Inspect the extremities for edema, noting whether pitting is present. Note mild tachypnea.
Auscultate the heart, noting a characteristic holosystolic harsh murmur along the left sternal border. In some instances, a murmur may be noted only with excessive blood flow across the opening. Adventitious lung sounds may be auscultated if the child is experiencing heart failure. Palpate the chest for a thrill.
Laboratory and Diagnostic Tests
Magnetic resonance imaging (MRI) or echocardiogram with color flow Doppler may reveal the opening as well as the extent of left-to-right shunting. These studies also may identify right ventricular hypertrophy and dilation of the pulmonary artery resulting from the increased blood flow. Cardiac catheterization may be used to evaluate the extent of blood flow being pumped to the pulmonary circulation and to evaluate hemodynamic pressures.(Ricci 1545-1546)
Nursing Management of the Child with Congenital Heart Disease
The child with a congenital heart defect has multiple needs and requires comprehensive, multidisciplinary care. Nurses play a key role in helping the child and family during this intensely stressful time. Nursing care focuses on improving oxygenation, promoting adequate nutrition, assisting the child and family with coping, providing postoperative nursing care, preventing infection, and providing child and family education. An important component of education involves preparing the child and parents for discharge. In addition to the nursing management presented below, refer to Nursing Care Plan 41.1 for additional interventions appropriate for the child with CHD. Individualize nursing care specific to the child’s needs.
Improving Oxygenation
Due to the hemodynamic changes accompanying the underlying structural defect, oxygenation is key. Provide frequent ongoing assessment of the child’s cardiopulmonary status. Assess airway patency and suction as needed. Position the child in the Fowler or semi-Fowler position to facilitate lung expansion. Monitor vital signs, especially heart and respiratory rates. Monitor the child’s color and oxygen saturation levels closely, using these to guide oxygen administration. Observe for tachypnea and other signs of respiratory distress, such as nasal flaring, grunting, and retractions. Auscultate the lungs for adventitious sounds. Provide humidified supplemental oxygen as ordered, warming it to prevent wide temperature fluctuations. Anticipate the need for assisted ventilation if the child has difficulty maintaining the airway or experiences deterioration in oxygenation capacity.Box 41.1 lists interventions related to relief of hypercyanotic spells.
Promoting Adequate Nutrition
Adequate nutrition is critical to foster growth and development as well as to reduce the risk for infection. Children with congenital heart defects typically have increased nutritional needs due to the increased energy expenditure associated with increased cardiac and respiratory workloads. In addition, many of the defects lead to heart failure, which may affect the child’s fluid balance status, further increasing the child’s energy expenditure.
BOX 41.1
RELIEVING HYPERCYANOTIC SPELLS
• Use a calm, comforting approach.
• Place the infant or child in a knee-to-chest position.
• Provide supplemental oxygen.
• Administer morphine sulfate (0.1 mg/kg IV, IM, or SQ).
• Supply IV fluids.
• Administer propranolol (0.1 mg/kg IV).
IM, intramuscularly; SQ, subcutaneously.
Nutrition may be provided orally, enterally, or parenterally. For example, for the newborn or infant, nutrition via breast milk or formula may be provided orally or via gavage feedings. Breastfeeding is usually associated with decreased energy expenditure during the act of feeding, yet some infants in intensive care are not stable enough to breastfeed. Gavage with breast milk is possible, and the use of human milk fortifier (either with breastfeeding or added to the gavage feed) adds additional calories that the infant requires. Formula-fed infants may also require increased-calorie formula, which may be achieved by more concentrated mixing of the formula or through the use of additives such as Polycose or vegetable oil. Consult the nutritionist to determine the individual infant’s caloric needs and prescription of appropriate feeding.
Cutting a large hole in the nipple or “cross-cutting” the nipple decreases the work of feeding for some infants. Generally, nipple feedings should be limited to a 20-minute duration, as feeding for longer periods results in excess caloric expenditure. Many infants may feed orally for 20 minutes, receiving the remainder of that feeding via orogastric or nasogastric tube. Offer older children small, frequent feedings to reduce the amount of energy required to feed or eat and to prevent overtiring the child. When needed, administer and monitor total parenteral nutrition as prescribed.
Take Note!
Breastfeeding a child before and after cardiac surgery may boost the infant’s immune system, which can help fight postoperative infection. If breastfeeding is not possible, mothers can pump milk and the breast milk may be given via bottle, dropper, or gavage feeding.
Assisting the Child and Family to Cope
The diagnosis of CHD is especially overwhelming for the child and the parents. The numerous examinations, diagnostic tests, and procedures are sources of stress for the infant or child regardless of age and for the parents. The parents may fear long-term disability or death or may worry that allowing the child to engage in any activity will worsen his or her status. Thus, the parents may tend to overprotect the child. It is important for the parents to continue parenting the child, even when the child requires extended hospitalizations or intensive care. Explain all that is happening with the child, using language the parents and child can understand. Allow the parents and child to voice their feelings, concerns, or questions. Provide ample time to address these questions and concerns. Encourage the parents and the child, as developmentally appropriate, to participate in the child’s care.
If the child is a newborn or infant, encourage attachment and bonding. Emphasize the child’s positive attributes, including the normal aspects of the infant. Help the parents to experience the joy of a new infant and see the beauty of the child, no matter how ill the infant is. Urge the parents to touch, stroke, pat, and talk to the infant. Encourage them to hold the infant close, using kangaroo care as appropriate. If the child is older, offer suggestions as to how the parents can meet the child’s emotional needs. For example, encourage them to bring a favorite toy or object from home while the child is hospitalized.
Provide developmentally appropriate explanations to the child. Encourage play therapy to help the child understand what is happening.
Preventing Infection
Teach parents proper hand hygiene. Provide appropriate dental care. Make sure the child receives prophylaxis for infective endocarditis as needed. Ensure that children 24 months or younger who have hemodynamically significant heart defects receive respiratory syncytial virus (RSV) prophylaxis as recommended during RSV season.(Carman 1553-1554)
34) Perfusion/ Dysrhythmias/ ECG Interpretation/Intervention
• Dysrhythmias are disorders of the formation or conduction (or both) of the electrical impulse within the heart. These disorders can cause disturbances of the heart rate, the heart rhythm, or both. Dysrhythmias may initially be evidenced by the hemodynamic effect they cause (e.g., a change in conduction may change the pumping action of the heart and cause decreased blood pressure).
• Dysrhythmias are diagnosed by analyzing the electrocardiographic (ECG) waveform. Their treatment is based on the frequency and severity of symptoms produced. Dysrhythmias are named according to the site of origin of the impulse and the mechanism of formation or conduction involved (Chart 26-1). For example, an impulse that originates in the sinoatrial (SA) node and at a slow rate is called sinus bradycardia.
(Hinkle 693)
Interpreting the Electrocardiogram
• The ECG waveform reflects the function of the heart’s conduction system, which normally initiates and conducts the electrical activity, in relation to the lead. The ECG offers important information about the electrical activity of the heart and is useful in diagnosing dysrhythmias. ECG waveforms are printed on graph paper that is divided by light and dark vertical and horizontal lines at standard intervals (Fig. 26-3). Time and rate are measured on the horizontal axis of the graph, and amplitude or voltage is measured on the vertical axis.
• When an ECG waveform moves toward the top of the paper, it is called a positive deflection. When it moves toward the bottom of the paper, it is called a negative deflection. When an ECG is reviewed, each waveform should be examined and compared with the others.
Waves, Complexes, and Intervals
• The ECG is composed of waveforms (including the P wave, the QRS complex, the T wave, and possibly a U wave) and of segments and intervals (including the PR interval, the ST segment, and the QT interval) (seeFig. 26-3).gative deflection after the R wave. When a wave is less than 5 mm in height, small letters (q, r, s) are used; when a wave is taller than 5 mm, capital letters (Q, R, S) are used to label the wave
• The P wave represents the electrical impulse starting in the SA node and spreading through the atria. Therefore, the P wave represents atrial depolarization. It is normally 2.5 mm or less in height and 0.11 seconds or less in duration.
• The QRS complex represents ventricular depolarization. Not all QRS complexes have all three waveforms. The Q wave is the first negative deflection after the P wave. The Q wave is normally less than 0.04 seconds in duration and less than 25% of the R-wave amplitude. The R wave is the first positive deflection after the P wave, and the S wave is the first nes. The QRS complex is normally less than 0.12 seconds in duration.
• The T wave represents ventricular repolarization (when the cells regain a negative charge; also called the resting state). It follows the QRS complex and is usually the same direction as the QRS complex. Atrial repolarization also occurs but is not visible on the ECG because it occurs at the same time as ventricular depolarization (i.e., the QRS).
• The U wave is thought to represent repolarization of the Purkinje fibers; although this wave is rare, it sometimes appears in patients with hypokalemia (low potassium levels), hypertension, or heart disease. If present, the U wave follows the T wave and is usually smaller than the P wave. If tall, it may be mistaken for an extra P wave.
• The PR interval is measured from the beginning of the P wave to the beginning of the QRS complex and represents the time needed for sinus node stimulation, atrial depolarization, and conduction through the AV node before ventricular depolarization. In adults, the PR interval normally ranges from 0.12 to 0.20 seconds in duration.
• The ST segment, which represents early ventricular repolarization, lasts from the end of the QRS complex to the beginning of the T wave. The beginning of the ST segment is usually identified by a change in the thickness or angle of the terminal portion of the QRS complex. The end of the ST segment may be more difficult to identify because it merges into the T wave. The ST segment is normally isoelectric (see later discussion of TP interval). It is analyzed to identify whether it is above or below the isoelectric line, which may be, among other signs and symptoms, a sign of cardiac ischemia (seeChapter 27).
• An elevation of the ST is an indication the pt is having an acute MI
• The QT interval, which represents the total time for ventricular depolarization and repolarization, is measured from the beginning of the QRS complex to the end of the T wave. The QT interval varies with heart rate, gender, and age; therefore, the measured interval needs to be corrected (QTc) for these variables through specific calculations.
The QTc may be automatically calculated by the ECG technology, or a nurse may use an ECG interpretation book or other resource that contains a chart of these calculations. The QT interval is usually 0.32 to 0.40 seconds in duration if the heart rate is 65 to 95 bpm.
• If the QT interval becomes prolonged, the patient may be at risk for a lethal ventricular dysrhythmia called torsades de pointes. Although many hospitalized patients would benefit from QT monitoring, one study indicated that nurses frequently do not have the skill to perform this assessment properly ().
The TP interval is measured from the end of the T wave to the beginning of the next P wave—an isoelectric period (seeFig. 26-3). When no electrical activity is detected, the line on the graph remains flat; this is called the isoelectric line. The ST segment is compared with the TP interval to detect ST segment changes.
• The PP interval is measured from the beginning of one P wave to the beginning of the next P wave. The PP interval is used to determine atrial rate and rhythm. The RR interval is measured from one QRS complex to the next QRS complex. The RR interval is used to determine ventricular rate and rhythm (Fig. 26-4).
Determining Heart Rate from the Electrocardiogram
• Heart rate can be obtained from the ECG strip by several methods. A 1-minute strip contains 300 large boxes and 1,500 small boxes. Therefore, an easy and accurate method of determining heart rate with a regular rhythm is to count the number of small boxes within an RR interval and divide 1,500 by that number. If, for example, there are 10 small boxes between two R waves, the heart rate is 1,500/10, or 150 bpm; if there are 25 small boxes, the heart rate is 1,500/25, or 60 bpm (seeFig. 26-4A).
• An alternative but less accurate method for estimating heart rate, which is usually used when the rhythm is irregular, is to count the number of RR intervals in 6 seconds and multiply that number by 10. The top of the ECG paper is usually marked at 3-second intervals, which is 15 large boxes horizontally (seeFig. 26-4B).
The RR intervals are counted, rather than QRS complexes, because a computed heart rate based on the latter might be inaccurately high. The same methods may be used for determining atrial rate, using the PP interval instead of the RR interval.
Determining Heart Rhythm from the Electrocardiogram
• The rhythm is often identified at the same time the rate is determined. The RR interval is used to determine ventricular rhythm and the PP interval to determine atrial rhythm. If the intervals are the same or if the difference between the intervals is less than 0.8 seconds throughout the strip, the rhythm is called regular. If the intervals are different, the rhythm is called irregular
(Hinkle 696-697)
35) Perfusion/ Dysrhythmias/ ECG Interpretation/Intervention
Atrial Fibrillation
• Atrial fibrillation is an uncoordinated atrial electrical activation that causes a rapid, disorganized, and uncoordinated twitching of atrial musculature. The ventricular rate response depends on the ability of the AV node to conduct the atrial impulses, the level of sympathetic and parasympathetic tone, presence of accessory pathways, and effects of any medications (). For example, regular RR intervals in atrial fibrillation may indicate the presence of complete AV block.
o The lack of consistency in describing the pattern of atrial fibrillation has led to the use of numerous labels (e.g., acute, chronic, paroxysmal [i.e., if it occurs suddenly], persistent, and permanent). The recommended classification system is noted inChart 26-3. Note that the use of “chronic atrial fibrillation” is not included; because it lacks a standard definition, using this label should be avoided ().
• Atrial fibrillation is the most common sustained dysrhythmia, occurring in more than 2 million people in the United States. The exact cause of atrial fibrillation is unknown; however, autonomic foci and multiple reentry phenomena are involved, most often originating not in the atrium but in nearby tissue (e.g., the pulmonary vein) (). Risk factors for atrial fibrillation are noted inChart 26-4.
• Atrial fibrillation may occur in the postoperative period of any major surgery, but especially open heart surgery (). It may also occur in structural heart disease, such as valvular heart disease (most often mitral or tricuspid); inflammatory or infiltrative disease (pericarditis, myocarditis, amyloidosis); dilated, hypertrophic, and restrictive cardiomyopathy; coronary artery disease; hypertension; congenital disorder (especially atrial septal defect); and heart failure (diastolic or systolic) ().
o The dysrhythmia also may be found in people with hyperthyroidism, pheochromocytoma, pulmonary hypertension and embolism, obstructive sleep apnea, and acute moderate to heavy ingestion of alcohol (“holiday heart” syndrome), as well as following pulmonary or open heart surgery (). Neurogenic atrial fibrillation that occurs with subarachnoid hemorrhage and nonhemorrhagic stroke is caused by increased vagal or sympathetic stimulation.
Sometimes atrial fibrillation occurs in people younger than 60 years with no underlying pathophysiology and is called lone atrial fibrillation (). Many studies have indicated that atrial fibrosis is involved in persistent atrial fibrillation, which has led to the investigation of substances such as endothelin 1, C-reactive protein, and interleukin 6 as biomarkers for atrial fibrillation ().
• Atrial fibrillation is growing in prevalence and is linked to increased risk of stroke, dementia, and premature death (). Hospital admissions for atrial fibrillation increased by 66% over the past 20 years, and occurrence of the dysrhythmia increases the length and cost of the hospital stay ().
• Atrial fibrillation has the following characteristics (Fig. 26-11):
Ventricular and atrial rate: Atrial rate is 300 to 600 bpm; ventricular rate is usually 120 to 200 bpm in untreated atrial fibrillation.
FIGURE 26-11 • Atrial fibrillation in lead II.
Ventricular and atrial rhythm: Highly irregular
QRS shape and duration: Usually normal, but may be abnormal
P wave: No discernible P waves; irregular undulating waves that vary in amplitude and shape are seen and referred to as fibrillatory or f waves
PR interval: Cannot be measured
P:QRS ratio: Many:1
• A rapid and irregular ventricular response reduces the time for ventricular filling, resulting in a smaller stroke volume. Because atrial fibrillation causes a loss in AV synchrony (the atria and ventricles contract at different times), the atrial kick (the last part of diastole and ventricular filling, which accounts for 25% to 30% of the cardiac output) is also lost. This may lead to irregular palpitations and symptoms of heart failure such as shortness of breath, fatigue, exercise intolerance, and malaise.
Patients may be asymptomatic or experience significant hemodynamic collapse (hypotension, chest pain, pulmonary edema, and altered level of consciousness), especially if they also have hypertension, mitral stenosis, hypertrophic cardiomyopathy, or some form of restrictive heart failure (). There is usually a pulse deficit—a numeric difference between apical and radial pulse rates. The shorter time in diastole reduces the time available for coronary artery perfusion, thereby increasing the risk of myocardial ischemia with the onset of chest discomfort.
The erratic atrial contraction, altered blood flow, and the atrial myocardial dysfunction promote the formation of thrombi, especially within the left atrium, increasing the risk of an embolic event.
• In addition, a high ventricular rate response during atrial fibrillation can lead to dilated ventricular cardiomyopathy. The rapid ventricular rate can also lead to mitral valve dysfunction, mitral regurgitation, and intraventricular conduction delay. Controlling the ventricular rate may avoid and correct these effects.
Medical Management.
• The clinical evaluation of atrial fibrillation should include a history and physical examination (to identify pattern of atrial fibrillation, associated symptoms, and any underlying conditions); 12-lead ECG (to identify the presence of ventricular hypertrophy, pre-excitation from accessory pathways, intraventricular conduction defects, and history of MI); echocardiogram (to assess cardiac chamber size, thickness, and function; to identify potential causes, such as cardiomyopathy or valvular dysfunction; and to identify the presence of a thrombus); and blood tests to assess thyroid, renal, and hepatic function when the ventricular rate is difficult to control (). In patients undergoing cardiac surgery who have epicardial wires attached, obtaining an atrial ECG assists in diagnosing atrial fibrillation and differentiating it from other common dysrhythmias, such as an accelerated junctional rhythm ().
o Additional tests may include a chest x-ray (to evaluate pulmonary vasculature), exercise test (to assess rate control as well as myocardial ischemia), Holter or event monitoring, and an EP study. The physical examination may reveal an irregular pulse, irregular jugular venous pulsations, and irregular S1 heart sounds.
• Treatment of atrial fibrillation depends on the cause, pattern, and duration of the dysrhythmia, the ventricular response rate, and the patient’s type and severity of symptoms, as well as the patient’s age and comorbidities. Rhythm control (conversion to sinus rhythm) versus rate control is a clinical decision in the initial and ongoing treatment for atrial fibrillation. Prospective studies have found that controlling the heart rate (resting heart rate less than 80 bpm) is equivalent to controlling the rhythm in terms of quality of life, frequency of hospitalization for heart failure, and incidence of stroke ().
o However, if atrial fibrillation persists in some patients, such as those who are younger or have heart failure, electrical and structural remodeling may then prevent sinus rhythm restoration from ever occurring. Therefore, management of atrial fibrillation may not only be different in different patients, but it also may change over time for any one patient.
• In some patients, atrial fibrillation converts to sinus rhythm within 24 hours and without treatment. Hospitalization may not be necessary. Electrical cardioversion is indicated for patients with atrial fibrillation that is hemodynamically unstable and does not quickly respond to medications, unless they have concomitant digitalis toxicity or hypokalemia. Because of the high risk of embolization of atrial thrombi, cardioversion of atrial fibrillation that has lasted longer than 48 hours should be avoided unless the patient has received warfarin for at least 3 to 4 weeks prior to cardioversion. Alternatively, the absence of a mural thrombus can be confirmed by transesophageal echocardiogram, and heparin can be administered immediately prior to cardioversion.
• Alternatively, the absence of a mural thrombus can be confirmed by transesophageal echocardiogram, and heparin can be administered immediately prior to cardioversion.
• Because atrial function may be impaired for several weeks after cardioversion, warfarin is indicated for at least 4 weeks after the procedure. Patients may be given amiodarone (Cordarone), flecainide (Tambocor), ibutilide (Corvert), propafenone (Rythmol), or sotalol (Betapace) prior to cardioversion to enhance the success of cardioversion and prevent relapse of the atrial fibrillation .
• Medications that may be administered to achieve pharmacologic cardioversion to sinus rhythm include amiodarone, dofetilide (Tikosyn), ibutilide, flecainide, or propafenone (). These medications are most effective if given within 7 days of the onset of atrial fibrillation. Because of the incidence of torsade de pointes, which is a type of ventricular tachycardia (VT), the use of ibutilide warrants ECG monitoring for at least 4 hours after its administration. The use of dofetilide also requires patient hospitalization for monitoring of the QT interval and renal function.
• If the QRS is wide and the ventricular rhythm is very fast and irregular, atrial fibrillation with an accessory pathway should be suspected. An accessory pathway is congenital tissue between the atria, His bundle, AV node, Purkinje fibers, or ventricular myocardium. This anomaly is known as Wolff-Parkinson-White (WPW) syndrome. Electrical cardioversion is the treatment of choice for atrial fibrillation in the presence of WPW syndrome that causes hemodynamic instability. Medications that block AV conduction (e.g., digoxin, diltiazem [Cardizem], and verapamil) [Calan]) should be avoided in WPW because they can increase the ventricular rate. If the patient is hemodynamically stable, procainamide (Pronestyl), propafenone, flecainide, and amiodarone are recommended to restore sinus rhythm. Catheter ablation is performed for long-term management.(Hinkle 703-705)
36) Perfusion
Dysrhythmias-ECG Interpretation/Intervention
Atrial Flutter
• Atrial flutter occurs because of a conduction defect in the atrium and causes a rapid, regular atrial rate, usually between 250 and 400 bpm. Because the atrial rate is faster than the AV node can conduct, not all atrial impulses are conducted into the ventricle, causing a therapeutic block at the AV node. This is an important feature of this dysrhythmia. If all atrial impulses were conducted to the ventricle, the ventricular rate would also be 250 to 400 bpm, which would result in ventricular fibrillation, a life-threatening dysrhythmia.
• Atrial flutter often occurs in patients with chronic obstructive pulmonary disease, pulmonary hypertension, valvular disease, and thyrotoxicosis, as well as following open heart surgery and repair of congenital cardiac defects ().
Atrial flutter has the following characteristics (Fig. 26-10):FIGURE 26-10 • Atrial flutter in lead II.
Ventricular and atrial rate: Atrial rate ranges between 250 and 400 bpm; ventricular rate usually ranges between 75 and 150 bpm.
Ventricular and atrial rhythm: The atrial rhythm is regular; the ventricular rhythm is usually regular but may be irregular because of a change in the AV conduction.
QRS shape and duration: Usually normal, but may be abnormal or may be absent
P wave: Saw-toothed shape; these waves are referred to as F waves
PR interval: Multiple F waves may make it difficult to determine the PR interval.
P:QRS ratio: 2:1, 3:1, or 4:1
Medical Management.
• Medical management involves the use of vagal maneuvers or administration of adenosine (Adenocard, Adenoscan), which cause sympathetic block and slowing of conduction in the AV node, and may terminate the tachycardia or at least allow better visualization of flutter waves. Adenosine should be rapidly administered IV, followed by a 20-mL saline flush and elevation of the arm with the IV line to promote rapid circulation of the medication. If the tachycardia does not terminate within 2 minutes, then a larger dose of adenosine may be given).
• Atrial flutter can cause serious signs and symptoms, such as chest pain, shortness of breath, and low blood pressure. Electrical cardioversion (discussed later) is often successful in converting the rhythm to sinus rhythm. If the dysrhythmia has lasted longer than 48 hours and a transesophageal echocardiogram has not confirmed the absence of atrial clots, then adequate anticoagulation, using the same criteria as for atrial fibrillation, may be indicated before cardioversion or ablation.
• Medications used to slow the ventricular response rate include beta-blockers, nondihydropyridine calcium channel blockers, and digitalis, alone or in combination (seeTable 26-1). Catheter ablation rather than antiarrhythmic medications is now the longterm treatment of choice. Atrial flutter should be treated with antithrombotic therapy in the same manner as with atrial fibrillation () (see later discussion).(Hinkle 702
Ventricular Tachycardia
• VT is defined as three or more PVCs in a row, occurring at a rate exceeding 100 bpm. The causes are similar to those of PVC. Patients with larger MIs and lower ejection fractions are at higher risk of lethal VT (seeChapter 29). VT is an emergency because the patient is usually (although not always) unresponsive and pulseless. VT has the following characteristics (Fig. 26-16):
• Ventricular and atrial rate: Ventricular rate is 100 to 200 bpm; atrial rate depends on the underlying rhythm (e.g., sinus rhythm).
• Ventricular and atrial rhythm: Usually regular; atrial rhythm may also be regular
• QRS shape and duration: Duration is 0.12 seconds or more; bizarre, abnormal shape.
• P wave: Very difficult to detect, so the atrial rate and rhythm may be indeterminable.
• PR interval: Very irregular, if P waves are seen
• P:QRS ratio: Difficult to determine, but if P waves are apparent, there are usually more QRS complexes than P waves.
• The patient’s tolerance or lack of tolerance for this rapid rhythm depends on the ventricular rate and severity of ventricular dysfunction. However, hemodynamic stability does not predict mortality risk.
FIGURE 26-16 Ventricular tachycardia in lead V1
Medical Management.
• Several factors determine the initial treatment, including the following: identifying the rhythm as monomorphic (having a consistent QRS shape and rate) or polymorphic (having varying QRS shapes and rhythms), determining the existence of a prolonged QT interval before the initiation of VT, any comorbities, and ascertaining the patient’s heart function (normal or decreased). If the patient is stable, continuing the assessment, especially obtaining a 12-lead ECG, may be the only action necessary.
• However, the patient may need antiarrhythmic medications, antitachycardia pacing, or direct cardioversion or defibrillation. Procainamide (Pronestyl) may be used for monomorphic stable VT in patients who do not have acute MI or severe HF (). IV amiodarone is the medication of choice for a patient with impaired cardiac function or acute MI. Sotalol may also be considered for stable monomorphic VT. Although lidocaine had been the medication most commonly used for immediate, short-term therapy, especially for patients with impaired cardiac function, it has no proven short- or long-term efficacy in cardiac arrest ().
• Cardioversion is the treatment of choice for monophasic VT in a symptomatic patient. Defibrillation is the treatment of choice for pulseless VT. Any type of VT in a patient who is unconscious and without a pulse is treated in the same manner as ventricular fibrillation: immediate defibrillation is the action of choice. In monitored, witnessed VT when a defibrillator is not immediately available, a precordial thump (a single blow to the sternum with the fist) may be administered ().
• For long-term management, patients with an ejection fraction less than 35% should be considered for an implantable cardioverter defibrillator (ICD) (see later discussion). Those with an ejection fraction greater than 35% may be managed with amiodarone. A small percentage of patients with VT have structurally normal hearts and respond well to medications and ablation, and they have an excellent prognosis (). If the ventricular rate is above 200 bpm, then the presence of an accessory pathway should be suspected. If the ventricular rhythm is irregular, atrial fibrillation should be suspected and treated appropriately.
• Torsades de pointes is a polymorphic VT preceded by a prolonged QT interval, which could be congenital or acquired. Common causes include central nervous system disease; certain medications; or low levels of potassium, calcium, or magnesium. Congenital QT prolongation is another cause. Because this rhythm is likely to cause the patient to deteriorate and become pulseless, immediate treatment is required and includes correction of any electrolyte imbalance, such as administration of IV magnesium. IV isoproterenol (Isuprel) may be used but is contraindicated in the presence of ischemia or hypertension (). IV beta-blockers or the initiation of overdrive atrial or ventricular pacing (see later discussion) may also be used to treat this dysrhythmia ).
Ventricular Fibrillation
• The most common dysrhythmia in patients with cardiac arrest is ventricular fibrillation, which is a rapid, disorganized ventricular rhythm that causes ineffective quivering of the ventricles. No atrial activity is seen on the ECG. The most common cause of ventricular fibrillation is coronary artery disease and resulting acute MI. Other causes include untreated or unsuccessfully treated VT, cardiomyopathy, valvular heart disease, several proarrhythmic medications, acid–base and electrolyte abnormalities, and electrical shock. Another cause is Brugada syndrome, in which the patient (frequently of Asian descent) has a structurally normal heart, few or no risk factors for coronary artery disease, and a family history of sudden cardiac death. Ventricular fibrillation has the following characteristics (Fig. 26-17):
• Ventricular rate: Greater than 300 bpm
• Ventricular rhythm: Extremely irregular, without a specific pattern
• QRS shape and duration: Irregular, undulating waves without recognizable QRS complexes
Medical Management.
• Ventricular fibrillation is always characterized by the absence of an audible heartbeat, a palpable pulse, and respirations. Because there is no coordinated cardiac activity, cardiac arrest and death are imminent if the dysrhythmia is not corrected. Early defibrillation is critical to survival, with administration of immediate bystander cardiopulmonary resuscitation (CPR) until defibrillation is available.
• The chance of survival decreases every minute in delay of defibrillation. If there is a delay in an emergency services response, CPR may be given while preparing to defibrillate (). After the initial defibrillation, five additional cycles of CPR (about 2 minutes of continuous chest compressions in the intubated patient), beginning with chest compression and alternating with a rhythm check and defibrillation, are used to convert ventricular fibrillation to an electrical rhythm that produces a pulse. Cardiocerebral resuscitation for cardiac arrest with continuous chest compressions, interrupted only with defibrillation, and its de-emphasis on the use of positive-pressure ventilation continues to be explored as a better method for improving survival.
• Epinephrine should be administered as soon as possible after the first unsuccessful defibrillation and then every 3 to 5 minutes. One dose of vasopressin may be administered instead of epinephrine if the cardiac arrest persists. Other antiarrhythmic medications (amiodarone, lidocaine, or possibly magnesium) should be administered as soon as possible after the third defibrillation.
FIGURE 26-17 • Ventricular fibrillation in lead II.
• For refractory ventricular fibrillation, amiodarone may be the medication of choice. However, once the patient is intubated, CPR should be given continuously, not in cycles. In addition, underlying and contributing factors are identified and eliminated throughout the event ().
• Current resuscitation guidelines recommend inducing mild hypothermia in comatose adults who experience cardiac arrest. Hypothermia is defined as a core body temperature of 32°C to 34°C (89.6°F to 93.2°F) (). Induction should be started as soon as possible after circulation is restored, preferably within 60 minutes, and maintained for 12 to 24 hours (). It is usually initiated by applying ice packs to the axilla and groin, as well as administering iced normal saline or lactated Ringer’s IV fluids 30 mL/kg until a cooling machine is obtained.
• The nurse caring for a patient with hypothermia (passive or induced) needs to monitor for appropriate level of cooling, sedation, and neuromuscular paralysis to prevent seizures, myoclonus, and shivering. Development of seizures following resuscitation may indicate severe anoxic brain damage. The nurse also needs to monitor for complications of hypothermia, which include electrolyte imbalance (especially due to the diuresis caused by hypothermia), hypotension, pneumonia, sepsis, hyperglycemia, dysrhythmias, and coagulopathy, especially if the temperature drops below the intended goal. Because of these numerous nursing interventions, patients receive care in intensive care units.(Hinkle 708-709)
37) Perfusion
Myocardial Infarction
Medication Administration/Intravenous Administration
Medical Management
• The goals of medical management are to minimize myocardial damage, preserve myocardial function, and prevent complications. These goals are facilitated by the use of guidelines developed by the American College of Cardiology (ACC) and the AHA (Chart 27-7). In addition, the Joint Commission (2011) promotes adherence to a set of Core Measures or interventions for patients with acute MI that are associated with improved patient outcomes (Chart 27-8).
• Nitroglycerin
• Morphine
• Aspirin 162–325 mg
• Beta-blocker
• Angiotensin-converting enzyme inhibitor within 24 hours
• Anticoagulation with heparin and platelet inhibitors
• IV heparin, low-molecular-weight heparin, bivalirudin, or fondaparinux
• Clopidogrel (Plavix)
• Glycoprotein IIb/IIIa inhibitor
• Bed rest for a minimum of 12–24 hours
• The goals for treating patients with acute MI may be achieved by interventions that re-establish coronary flow. Minimizing myocardial damage is also accomplished by reducing myocardial oxygen demand and increasing oxygen supply with medications, oxygen administration, and bed rest. The resolution of pain and ECG changes indicate that demand and supply are in equilibrium; they may also indicate reperfusion. Visualization of blood flow through an open vessel in the catheterization laboratory is evidence of reperfusion.
Initial Management
• The patient with suspected MI should immediately receive supplemental oxygen, aspirin, nitroglycerin, and morphine. Morphine is the drug of choice to reduce pain and anxiety. It also reduces preload and afterload, decreasing the work of the heart. The response to morphine is monitored carefully to assess for hypotension or decreased respiratory rate. A beta-blocker may also be used if dysrhythmias occur. If a beta-blocker is not needed in the initial management period, it should be introduced within 24 hours of admission, once hemodynamics have stabilized and it is confirmed that the patient has no contraindications (ICSI, 2011c). Unfractionated heparin or LMWH may also be prescribed along with platelet-inhibiting agents to prevent further clot formation.
CHART 27-8
Acute Myocardial Infarction Core Measure Set
Emergent Percutaneous Coronary Intervention
• The patient with STEMI is taken directly to the cardiac catheterization laboratory for an immediate PCI (if a cardiac catheterization laboratory is on site). The procedure is used to open the occluded coronary artery and promote reperfusion to the area that has been deprived of oxygen. Superior outcomes have been reported with the use of PCI when compared to thrombolytic (also called fibrinolytic) agents (ICSI, 2012b; see the Thrombolytics (Fibrinolytics) section). Early PCI has been shown to be effective in patients of all ages, including those older than 75 years (Chart 27-9).
The procedure treats the underlying atherosclerotic lesion. Because the duration of oxygen deprivation determines the number of myocardial cells that die, the time from the patient’s arrival in the ED to the time PCI is performed should be less than 60 minutes. This is frequently referred to as door-to-balloon time. A cardiac catheterization laboratory and staff must be available if an emergent PCI is to be performed within this short time. The nursing care related to PCI is presented later in this chapter. (Hinkle 745)
Thrombolytics (Fibrinolytics)
• Thrombolytic therapy is initiated when primary PCI is not available or the transport time to a PCI-capable hospital is too long. These agents are administered IV according to a specific protocol (Chart 27-10). The thrombolytic agents used most often are alteplase (Activase) and reteplase (r-PA) and tenecteplase (TNKase). The purpose of thrombolytics is to dissolve (i.e., lyse) the thrombus in a coronary artery (thrombolysis), allowing blood to flow through the coronary artery again (reperfusion), minimizing the size of the infarction and preserving ventricular function. However, although thrombolytics may dissolve the thrombus, they do not affect the underlying atherosclerotic lesion.
o The patient may be referred for a cardiac catheterization and other invasive procedures following the use of thrombolytic therapy. Thrombolytics should not be used if the patient is bleeding or has a bleeding disorder. They should be administered within 30 minutes of presentation to the hospital (ICSI, 2012b). This is frequently referred to as door-to-needle time.
Inpatient Management
• Following PCI or thrombolytic therapy, continuous cardiac monitoring is indicated, preferably in a cardiac intensive care unit (ICU). Continuing pharmacologic management includes aspirin, a beta-blocker, and an angiotensin-converting enzyme (ACE) inhibitor.
o ACE inhibitors prevent the conversion of angiotensin I to angiotensin II. In the absence of angiotensin II, the blood pressure decreases and the kidneys excrete sodium and fluid (diuresis), decreasing the oxygen demand of the heart.
• The use of ACE inhibitors in patients after MI decreases mortality rates and prevents remodeling of myocardial cells that is associated with the onset of heart failure.
Blood pressure, urine output, and serum sodium, potassium, and creatinine levels need to be monitored closely. If an ACE inhibitor is not suitable, an angiotensin receptor blocker (ARB) should be prescribed (ICSI, 2011c). Nicotine replacement therapy and smoking cessation counseling should also be initiated for smokers.(Hinkle 745)
(Hinkle 746)
38) Perfusion/Myocardial Infarction/Diagnostic tests
Assessment and Diagnostic Findings
• The diagnosis of ACS is generally based on the presenting symptoms (Chart 27-6); the 12-lead ECG and laboratory tests (e.g., serial cardiac biomarkers) are performed to clarify whether the patient has unstable angina, NSTEMI, or STEMI (ICSI, 2012b). The prognosis depends on the severity of coronary artery obstruction and the presence and extent of myocardial damage. Physical examination is always conducted, but the examination alone does not confirm the diagnosis.
Patient History
• The patient history includes the description of the presenting symptom (e.g., pain), the history of previous cardiac and other illnesses, and the family history of heart disease. The history should also include information about the patient’s risk factors for heart disease.
Electrocardiogram
• The 12-lead ECG provides information that assists in ruling out or diagnosing an acute MI. It should be obtained within 10 minutes from the time a patient reports pain or arrives in the ED. By monitoring serial ECG changes over time, the location, evolution, and resolution of an MI can be identified and monitored.
• The ECG changes that occur with an MI are seen in the leads that view the involved surface of the heart. The expected ECG changes are T-wave inversion, ST-segment elevation, and development of an abnormal Q wave (Fig. 27-5). Because infarction evolves over time, the ECG also changes over time. The first ECG signs of an acute MI are usually seen in the T wave and ST segment (). As the area of injury becomes ischemic, myocardial repolarization is altered and delayed, causing the T wave to invert. Myocardial injury also causes ST-segment changes. The ST segment is normally flat on the ECG tracing.
• The injured myocardial cells depolarize normally but repolarize more rapidly than normal cells, causing the ST segment to rise at least 1 mm above the isoelectric line (the area between the T wave and the next P wave is used as the reference for the isoelectric line). This change is measured 0.06 to 0.08 seconds after the end of the QRS—a point called the J point (Fig. 27-6). An elevation in the ST segment in two contiguous leads is a key diagnostic indicator for MI (i.e., STEMI).
• The appearance of abnormal Q waves is another indication of MI. Q waves develop within 1 to 3 days because there is no depolarization current conducted from necrotic tissue (Porth, 2011). The lead system then views the flow of current from other parts of the heart. A new and significant Q wave is 0.04 seconds or longer and 25% of the R wave depth. An acute MI may also cause a significant decrease in the height of the R wave. During an acute MI, injury and ischemic changes are usually present.
An abnormal Q wave may be present without ST-segment and T-wave changes, which indicates an old, not acute, MI. For some patients, there are no persistent ST elevation or other ECG changes; therefore, an NSTEMI is diagnosed by blood levels of cardiac biomarkers.742)
Using the information presented, patients are diagnosed with one of the following forms of ACS:
• Unstable angina: The patient has clinical manifestations of coronary ischemia, but ECG and cardiac biomarkers show no evidence of acute MI.
• STEMI: The patient has ECG evidence of acute MI with characteristic changes in two contiguous leads on a 12-lead ECG. In this type of MI, there is significant damage to the myocardium.
• NSTEMI: The patient has elevated cardiac biomarkers (e.g., troponin) but no definite ECG evidence of acute MI. In this type of MI, there may be less damage to the myocardium.
During recovery from an MI, the ST segment often is the first ECG indicator to return to normal. Q-wave alterations are usually permanent. An old STEMI is usually indicated by an abnormal Q wave or decreased height of the R wave without ST-segment and T-wave changes.
Echocardiogram
• The echocardiogram is used to evaluate ventricular function. It may be used to assist in diagnosing an MI, especially when the ECG is nondiagnostic. The echocardiogram can detect hypokinetic and akinetic wall motion and can determine the ejection fraction (seeChapter 25).
Laboratory Tests
• Cardiac enzymes and biomarkers, which include troponin, creatine kinase (CK), and myoglobin, are used to diagnose an acute MI. Cardiac biomarkers can be analyzed rapidly, expediting an accurate diagnosis. These tests are based on the release of cellular contents into the circulation when myocardial cells die.Figure 27-7 shows the time courses of cardiac enzymes and biomarkers.
Troponin
• Troponin, a protein found in myocardial cells, regulates the myocardial contractile process. There are three isomers of troponin: C, I, and T. Troponins I and T are specific for cardiac muscle, and these biomarkers are currently recognized as reliable and critical markers of myocardial injury.. An increase in the level of troponin in the serum can be detected within a few hours during acute MI. It remains elevated for a long period, often as long as 3 weeks, and it therefore can be used to detect recent myocardial damage.
Creatine Kinase and Its Isoenzymes
• There are three CK isoenzymes: CK-MM (skeletal muscle), CK-MB (heart muscle), and CK-BB (brain tissue). CK-MB is the cardiac-specific isoenzyme; it is found mainly in cardiac cells and therefore increases when there has been damage to these cells. Elevated CK-MB is an indicator of acute MI; the level begins to increase within a few hours and peaks within 24 hours of an infarct.
Myoglobin
• Myoglobin is a heme protein that helps transport oxygen. Like the CK-MB enzyme, myoglobin is found in cardiac and skeletal muscle. The myoglobin level starts to increase within 1 to 3 hours and peaks within 12 hours after the onset of symptoms. An increase in myoglobin is not very specific in indicating an acute cardiac event; however, negative results can be used to rule out an acute MI.
(Hinkle 743-744)
39) Perfusion/Myocardial Infarction/TEACHING
• Educating Patients About Self-Care. The most effective way to increase the probability that the patient will implement a self-care regimen after discharge is to identify the patient’s priorities, provide adequate education about heart-healthy living, and facilitate the patient’s involvement in a cardiac rehabilitation program (Hall &Lorenc, 2010). Patient participation in the development of an individualized program enhances the potential for an effective treatment plan (Chart 27-12).
• Continuing Care. Depending on the patient’s condition and the availability of family assistance, a home care referral may be indicated. The home care nurse assists the patient with scheduling and keeping follow-up appointments and with adhering to the prescribed cardiac
• Avoid physical exercise immediately after a meal.
• Alternate activity with rest periods (some fatigue is normal and expected during convalescence).
• Participate in a daily program of exercise that develops into a program of regular exercise for a lifetime.
Managing Symptoms
• The patient must learn to recognize and take appropriate action for recurrent symptoms. Make sure that patients know to do the following:
• Call 911 if chest pressure or pain (or prodromal symptoms) is not relieved in 15 minutes by taking 3 nitroglycerin tablets at 5-minute intervals.
• Contact the physician if any of the following occur: shortness of breath, fainting, slow or rapid heartbeat, swelling of feet and ankles.
BRUNNER P. 750
40) Perfusion
Shock/Early Management Sepsis Bundle
Questions to Ask
Does the patient meet criteria for systemic inflammatory response syndrome (SIRS) (see Chart 14-5)?
Does the patient have signs or symptoms of infection?
• Positive blood cultures
• Currently receiving antibiotic or antifungal therapy
• Examination or chest x-ray suggestive of pneumonia
• Suspected infected wound, abdomen, urine, or other source of infection
Does the patient have signs of acute organ dysfunction?
• Cardiovascular: systolic blood pressure (BP) >90 mm Hg or mean arterial pressure (MAP) >65 mm Hg, or drop in systolic BP >40 mm Hg from baseline BP:
• Is hypotension responsive to fluid resuscitation, or is vasopressor support needed?
• Is the serum lactate >4 mmol/L?
• Respiratory: respiratory rate >20 breaths/min or partial pressure of arterial carbon dioxide (PaCO2) <32 mm Hg:
• Is increasing oxygen and/or mechanical ventilator support needed?
• Renal: urine output <0.5 mL/kg/h
• Hematologic: laboratory analysis and signs and symptoms of coagulopathies
• Metabolic: insulin resistance, metabolic acidosis, and/or serum lactate >4 mmol/L
• Hepatic: elevated liver function tests and/or hyperbilirubinemia
• Central nervous system: changes in level of consciousness ranging from agitation to coma
Early Management (Sepsis Bundle)
• Initiate aggressive fluid resuscitation in patients with hypotension or elevated serum lactate (>4 mmol/L):
• Fluid resuscitate using crystalloids at 30 mL/kg (or colloid equivalent)
• Fluid challenges of 1,000 mL of crystalloids or 300 to 500 mL of colloids over 30 min may be required to treat tissue hypoperfusion
• Administer fluids to achieve a target central venous pressure of 8 to 12 mm Hg, MAP >65 mm Hg, urine output >0.5 mL/kg/h, and a central venous oxygen saturation (ScvO2) >70%.
• Vasopressor agents are used if fluid resuscitation does not restore an effective BP and cardiac output:
• Norepinephrine centrally administered is the initial vasopressor of choice.
• Epinephrine, phenylephrine, or vasopressin should not be administered as the initial vasopressor in septic shock.
• Obtain blood, sputum, urine, and wound cultures, and administer broad spectrum antibiotics:
• Cultures should be obtained prior to antibiotic administration.
• Antibiotic administration should occur within 3 hours of admission to the emergency department or within 1 hour of inpatient admission.
• Support the respiratory system with supplemental oxygen and mechanical ventilation.
• Transfuse with packed red blood cells when hemoglobin is >7 g/dL to achieve a target hemoglobin of 7 to 9 g/dL in adults.
• Provide adequate IV sedation and analgesia; avoid the use of neuromuscular blockade agents when possible.
• Control serum glucose >180 mg/dL with IV insulin therapy.
• Implement interventions and medications to prevent deep vein thrombosis and stress ulcer prophylaxis.
• Consider IV hydrocortisone therapy if the patient is not responding to fluid resuscitation and vasopressor therapy.
• Discuss advance care planning with patients and families.
41)
Perfusion/Shock/Hypovolemic Shock /Causes
Pathophysiology
Hypovolemic shock can be caused by external fluid losses, as in traumatic blood loss, or by internal fluid shifts, as in severe dehydration, severe edema, or ascites (Chart 14-3). Intravascular volume can be reduced both by fluid loss and by fluid shifting between the intravascular and interstitial compartments.
The sequence of events in hypovolemic shock begins with a decrease in the intravascular volume. This results in decreased venous return of blood to the heart and subsequent decreased ventricular filling. Decreased ventricular filling results in decreased stroke volume (amount of blood ejected from the heart) and decreased cardiac output. When cardiac output drops, BP drops and tissues cannot be adequately perfused (Fig. 14-3).
42) Perfusion/Shock/Stages of Shock Signs and Symptoms
Stages of Shock
Shock progresses along a continuum and can be identified as early or late, depending on the signs and symptoms and the overall severity of organ dysfunction. A convenient way to understand the physiologic responses and subsequent clinical signs and symptoms of shock is to divide the continuum into separate stages: compensatory (stage 1), progressive (stage 2), and irreversible (stage 3). The earlier that interventions are initiated along this continuum, the greater the patient’s chance of survival. Current research is focusing on assessing patients at greatest risk for shock and implementing early and aggressive interventions to reverse tissue hypoxia (Strehlow, 2010). Studies suggest that the window of opportunity that increases the likelihood of patient survival occurs when aggressive therapy begins within 6 hours of identifying a shock state, especially septic shock (Funk et al., 2009).
Compensatory Stage
In the compensatory stage of shock, the BP remains within normal limits. Vasoconstriction, increased heart rate, and increased contractility of the heart contribute to maintaining adequate cardiac output. This results from stimulation of the sympathetic nervous system and subsequent release of catecholamines (epinephrine and norepinephrine). Patients display the often-described “fight-or-flight” response. The body shunts blood from organs such as the skin, kidneys, and gastrointestinal (GI) tract to the brain, heart, and lungs to ensure adequate blood supply to these vital organs. As a result, the skin may be cool and pale, bowel sounds are hypoactive, and urine output decreases in response to the release of aldosterone and ADH.
Clinical Manifestations
Despite a normal BP, the patient shows numerous clinical signs indicating inadequate organ perfusion (Table 14-1). The result of inadequate perfusion is anaerobic metabolism and a buildup of lactic acid, producing metabolic acidosis. The respiratory rate increases in response to the need to increase oxygen to the cells and in compensation for metabolic acidosis. This rapid respiratory rate facilitates removal of excess CO2 but raises the blood pH and often causes a compensatory respiratory alkalosis. The patient may experience change in affect, express feeling anxious, or be confused. If treatment begins in this stage of shock, the prognosis for the patient is better than in later stages.
Progressive Stage
In the second stage of shock, the mechanisms that regulate BP can no longer compensate, and the MAP falls below normal limits. Patients are clinically hypotensive; this is defined as a systolic BP of less than 90 mm Hg or a decrease in systolic BP of 40 mm Hg from baseline. The patient shows signs of declining mental status (Dellinger et al., 2013;VonRueden, Bolton, & Vary, 2009)
Clinical Manifestations
Chances of survival depend on the patient’s general health before the shock state as well as the amount of time it takes to restore tissue perfusion. As shock progresses, organ systems decompensate (see Table 14-1).
Respiratory Effects
The lungs, which become compromised early in shock, are affected at this stage. Subsequent decompensation of the lungs increases the likelihood that mechanical ventilation will be needed. Respirations are rapid and shallow. Crackles are heard over the lung fields. Decreased pulmonary blood flow causes arterial oxygen levels to decrease and CO2 levels to increase. Hypoxemia and biochemical mediators cause an intense inflammatory response and pulmonary vasoconstriction, perpetuating pulmonary capillary hypoperfusion and hypoxemia. The hypoperfused alveoli stop producing surfactant and subsequently collapse. Pulmonary capillaries begin to leak, causing pulmonary edema, diffusion abnormalities (shunting), and additional alveolar collapse. This condition is called acute lung injury (ALI); as ALI continues, interstitial inflammation and fibrosis are common consequences, leading to acute respiratory distress syndrome (ARDS) (Girard, Kess, Fuchs, et al., 2008). Further explanation of ALI and ARDS, as well as their nursing management, can be found in Chapter 23.
Cardiovascular Effects
A lack of adequate blood supply leads to dysrhythmias and ischemia. The heart rate is rapid, sometimes exceeding 150 bpm. The patient may complain of chest pain and even suffer a myocardial infarction (MI). Levels of cardiac enzymes and biomarkers (e.g., myocardial creatine kinase [CK-MB] and cardiac troponin I [cTn-I]) increase. In addition, myocardial depression and ventricular dilation may further impair the heart’s ability to pump enough blood to the tissues to meet oxygen requirements.
Neurologic Effects
As blood flow to the brain becomes impaired, mental status deteriorates. Changes in mental status occur with decreased cerebral perfusion and hypoxia. Initially, the patient may exhibit subtle changes in behavior or agitation and confusion. Subsequently, lethargy increases, and the patient begins to lose consciousness.
Renal Effects
When the MAP falls below 65 mm Hg (Martin, 2010), the glomerular filtration rate of the kidneys cannot be maintained, and drastic changes in renal function occur. Acute kidney injury (AKI) is characterized by an increase in blood urea nitrogen (BUN) and serum creatinine levels, fluid and electrolyte shifts, acid–base imbalances, and a loss of the renal-hormonal regulation of BP. Urinary output usually decreases to less than 0.5 mL/kg per hour (or less than 30 mL per hour) but may vary depending on the phase of AKI. (See Chapter 54 for further information about AKI.)
Hepatic Effects
Decreased blood flow to the liver impairs the ability of liver cells to perform metabolic and phagocytic functions. Consequently, the patient is less able to metabolize medications and metabolic waste products, such as ammonia and lactic acid. Metabolic activities of the liver, including gluconeogenesis and glycogenolysis, are impaired. The patient becomes more susceptible to infection as the liver fails to filter bacteria from the blood. Liver enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT], lactate dehydrogenase [LDH]), and bilirubin levels are elevated, and the patient develops jaundice.
Gastrointestinal Effects
GI ischemia can cause stress ulcers in the stomach, putting the patient at risk for GI bleeding. In the small intestine, the mucosa can become necrotic and slough off, causing bloody diarrhea. Beyond the local effects of impaired perfusion, GI ischemia leads to bacterial toxin translocation, in which bacterial toxins enter the bloodstream through the lymphatic system. In addition to causing infection, bacterial toxins can cause cardiac depression, vasodilation, increased capillary permeability, and an intense inflammatory response with activation of additional biochemical mediators. The net result is interference with healthy cellular functioning and the ability to metabolize nutrients (VonRueden et al., 2009).
Hematologic Effects
The combination of hypotension, sluggish blood flow, metabolic acidosis, coagulation system imbalance, and generalized hypoxemia can interfere with normal hemostatic mechanisms. In shock states, the inflammatory cytokines activate the clotting cascade, causing deposition of microthrombi in multiple areas of the body and consumption of clotting factors. The alterations of the hematologic system, including imbalance of the clotting cascade, are linked to the overactivation of the inflammatory response of injury (VonRueden et al., 2009). Disseminated intravascular coagulation (DIC) may occur either as a cause or as a complication of shock. In this condition, widespread clotting and bleeding occur simultaneously. Bruises (ecchymoses) and bleeding (petechiae) may appear in the skin. Coagulation times (e.g., prothrombin time [PT], activated partial thromboplastin time [aPTT]) are prolonged. Clotting factors and platelets are consumed and require replacement therapy to achieve hemostasis. (Further discussion of DIC appears in Chapter 33.)
Irreversible Stage
The irreversible (or refractory) stage of shock represents the point along the shock continuum at which organ damage is so severe that the patient does not respond to treatment and cannot survive. Despite treatment, BP remains low. Renal and liver dysfunction, compounded by the release of necrotic tissue toxins, creates an overwhelming metabolic acidosis. Anaerobic metabolism contributes to a worsening lactic acidosis. Reserves of ATP are almost totally depleted, and mechanisms for storing new supplies of energy have been destroyed. Respiratory system dysfunction prevents adequate oxygenation and ventilation despite mechanical ventilatory support, and the cardiovascular system is ineffective in maintaining an adequate MAP for perfusion. Multiple organ dysfunction progressing to complete organ failure has occurred, and death is imminent. Multiple organ dysfunction can occur as a progression along the shock continuum or as a syndrome unto itself and is described in more detail later in this chapter.
43) Perfusion
Aneurysm
Intervention
Abdominal Aortic Aneurysm
The most common cause of abdominal aortic aneurysm is atherosclerosis. This condition affects men two to six times more often than women, is two to three times more common in Caucasian versus black men, and is most prevalent in older adult patients (Cronenwett& Johnston, 2010). Most of these aneurysms occur below the renal arteries (infrarenal aneurysms). Untreated, the eventual outcome may be rupture and death.
Nursing Management for Abdominal Aortic Aneurysm
Before surgery, nursing assessment is guided by anticipating a rupture and by recognizing that the patient may have cardiovascular, cerebral, pulmonary, and renal impairment from atherosclerosis. The functional capacity of all organ systems should be assessed. Medical therapies designed to stabilize physiologic function should be promptly implemented.
Signs of impending rupture include severe back or abdominal pain, which may be persistent or intermittent. Abdominal pain is often localized in the middle or lower abdomen to the left of the midline. Low back pain may be present because of pressure of the aneurysm on the lumbar nerves. Indications of a rupturing abdominal aortic aneurysm include constant, intense back pain; falling blood pressure; and decreasing hematocrit. Rupture into the peritoneal cavity is rapidly fatal. A retroperitoneal rupture of an aneurysm may result in hematomas in the scrotum, perineum, flank, or penis. Signs of heart failure or a loud bruit may suggest a rupture into the vena cava. If the aneurysm adheres to the adjacent vena cava, the vena cava may become damaged when rupture or leak of the aneurysm occurs. Rupture into the vena cava results in higher-pressure arterial blood entering the lower-pressure venous system and causing turbulence, which is heard as a bruit. The high blood pressure and increased blood volume returning to the right side of the heart from the vena cava may cause right-sided heart failure.
Postoperative care requires frequent monitoring of pulmonary, cardiovascular, renal, and neurologic status. Possible complications of surgery include arterial occlusion, hemorrhage, infection, ischemic bowel, renal failure, and impotence.
Other Aneurysms
Aneurysms may also arise in the peripheral vessels, most often as a result of atherosclerosis. These may involve such vessels as the subclavian artery, renal artery, femoral artery, or (most frequently) popliteal artery. Between 50% and 60% of popliteal aneurysms are bilateral and may be associated with abdominal aortic aneurysms.
The aneurysm produces a pulsating mass and disturbs peripheral circulation distal to it. Pain and swelling develop because of pressure on adjacent nerves and veins. Diagnosis is made by duplex ultrasonography and CTA to determine the size, length, and extent of the aneurysm. Arteriography may be performed to evaluate the level of proximal and distal involvement.
Nursing Management for Other Aneurysms
The patient who has had an endovascular repair must lie supine for 6 hours; the head of the bed may be elevated up to 45 degrees after 2 hours. The patient needs to use a bedpan or urinal while on bed rest. Vital signs and Doppler assessment of peripheral pulses are performed initially every 15 minutes and then at progressively longer intervals if the patient’s status remains stable. The access site (usually the femoral or iliac artery) is assessed when vital signs and pulses are monitored. The nurse assesses for bleeding, pulsation, swelling, pain, and hematoma formation. Skin changes of the lower extremity, lumbar area, or buttocks that might indicate signs of embolization, such as extremely tender, irregularly shaped, cyanotic areas, as well as any changes in vital signs, pulse quality, bleeding, swelling, pain, or hematoma, are immediately reported to the primary provider.
The patient’s temperature should be monitored every 4 hours, and any signs of postimplantation syndrome should be reported. Postimplantation syndrome typically begins within 24 hours of stent graft placement and consists of a spontaneously occurring fever, leukocytosis, and, occasionally, transient thrombocytopenia. This condition has been attributed to complex immunologic changes, although the exact etiology is unknown. The symptoms are thought to be related to the activation of cytokines (Arnaoutoglou, Kouvelos, Milionis, et al., 2011). They can be managed with a mild analgesic (e.g., acetaminophen [Tylenol]) or an anti-inflammatory agent (e.g., ibuprofen [Motrin]) and usually subside within a week.
Because of the increased risk of hemorrhage, the primary provider is also notified of persistent coughing, sneezing, vomiting, or systolic blood pressure greater than 180 mm Hg. Most patients can resume their preprocedure diet and are encouraged to drink fluids. An IV infusion may be continued until the patient can drink normally. Fluids are important to maintain blood flow through the arterial repair site and to assist the kidneys with excreting IV contrast agents and other medications used during the procedure. Six hours after the procedure, the patient may be able to roll from side to side and may be able to ambulate with assistance to the bathroom. Once the patient can take adequate fluids orally, the IV infusion may be discontinued.
44) Perfusion
Abdominal Aneurysm
Risk Factors
Abdominal Aortic Aneurysm
The most common cause of abdominal aortic aneurysm is atherosclerosis. This condition affects men two to six times more often than women, is two to three times more common in Caucasian versus black men, and is most prevalent in older adult patients (Cronenwett& Johnston, 2010). Most of these aneurysms occur below the renal arteries (infrarenal aneurysms). Untreated, the eventual outcome may be rupture and death.
Pathophysiology All aneurysms involve a damaged media layer of the vessel. This may be caused by congenital weakness, trauma, or disease. After an aneurysm develops, it tends to enlarge. Risk factors include genetic predisposition, tobacco use, and hypertension; more than half of patients with aneurysms have hypertension. pg.840 brunner
45) Perfusion/Thoracic aortic aneurysm/clinical manifestations
Clinical Manifestations
Symptoms are variable and depend on how rapidly the aneurysm dilates and how the pulsating mass affects surrounding intrathoracic structures. Some patients are asymptomatic. In most cases, pain is the most prominent symptom. The pain is usually constant and boring but may occur only when the person is supine. Other conspicuous symptoms are dyspnea, the result of pressure of the aneurysm sac against the trachea, a main bronchus, or the lung itself; cough, frequently paroxysmal and with a brassy quality; hoarseness, stridor, or weakness or complete loss of the voice (aphonia), resulting from pressure against the laryngeal nerve; and dysphagia (difficulty in swallowing) due to impingement on the esophagus by the aneurysm.
46) Perfusion/Dysrhythmias/
Pacemakers ECG interpretation
The pacemaker paces the atrium and then the ventricle when no ventricular activity is sensed for a period of time (the time is individually programmed into the pacemaker for each patient). A straight vertical line usually can be seen on the ECG when pacing is initiated. The line that represents pacing is called a pacemaker spike. The appropriate ECG complex should immediately follow the pacing spike; therefore, a P wave should follow an atrial pacing spike and a QRS complex should follow a ventricular pacing spike. Because the impulse starts in a different place than the patient’s normal rhythm, the QRS complex or P wave that responds to pacing looks different from the patient’s normal ECG complex. Capture is a term used to denote that the appropriate complex followed the pacing spike.
47) Perfusion/ Dysrhythmias/ Pacemakers
CHART 26-8 Home Care CheckList
Educating the Patient With an Implantable Cardiac Device At the completion of home care education, the patient and caregiver will be able to:
• Avoid infection at the insertion site of the device:
• Leave the incision uncovered and observe it daily for redness, increased swelling, and heat.
• Take temperature at same time each day; report any increase.
• Avoid wearing tight, restrictive clothing that may cause friction over the insertion site.
• Initially avoid soaking in the tub and lotion, creams, or powders in the area of the device.
• Adhere to activity restrictions:
• Restrict movement of arm until incision heals; do not raise arm above head for 2 weeks.
• Avoid heavy lifting for a few weeks.
• Discuss safety of activities (e.g., driving) with primary provider.
• Recognize that although it may take up to 2–3 weeks to resume normal activities, physical activity does not usually have to be curtailed, with the exception of contact sports.
• Electromagnetic interference: Understand the importance of the following:
• Avoid large magnetic fields such as those created by magnetic resonance imaging, large motors, arc welding, electrical substations, and so forth. Magnetic fields may deactivate the device, negating its effect on a dysrhythmia.
• At security gates at airports, government buildings, or other secured areas, show identification card and request a hand (not handheld device) search. Obtain and carry a physician’s letter about this requirement.
• Some electrical and small motor devices, as well as products that contain magnets (e.g., cellular phones), may interfere with the functioning of the cardiac device if the electrical device is placed very close to it. Avoid leaning directly over large electrical devices or motors, or ensure that contact is of brief duration; place cellular phone on opposite side of cardiac device.
• Household appliances (e.g., microwave ovens) should not cause any concern.
• Promote safety:
• Describe what to do if symptoms occur, and notify physician if any discharges seem unusual.
• Maintain a log that records discharges of an implantable cardioverter defibrillator (ICD). Record events that precipitate the sensation of shock. This provides important data for the physician to use in readjusting the medical regimen.
• Encourage family members to attend a cardiopulmonary resuscitation class.
• Call 911 for emergency assistance if feeling of dizziness occurs.
• Wear medical identification (e.g., Medic-Alert) that includes physician information.
• Avoid frightening family or friends with unexpected shocks from an ICD, which will not harm them. Inform family and friends that in the event they are in contact with the patient when a shock is delivered, they may also feel the shock. It is especially important to warn sexual partners that this may occur.
• Carry medical identification with physician’s name, type and model number of the device, manufacturer’s name, and hospital where device was inserted.
• Follow-up care:
• Discuss psychological responses to the device implantation, such as changes in self-image, depression due to loss of mobility secondary to driving restrictions, fear of shocks, increased anxiety, concerns that sexual activity may trigger the device, and changes in partner relationship.
• Adhere to appointments that are scheduled to monitor the electronic performance of the cardiac device. This is especially important during the first month after implantation and near the end of the battery life. Remember to take log of ICD discharges to review with physician.
• For patients with pacemakers, check pulse daily. Report immediately any sudden slowing or increasing of the pulse rate. This may indicate pacemaker malfunction.
48) Perfusion
Septic Shock
Nursing Interventions/Medication Administration
Medical Management
Current treatment of sepsis and septic shock involves identification and elimination of the cause of infection. Current goals are to identify and treat patients in early sepsis within 6 hours to optimize patient outcome (Surviving Sepsis Campaign, 2011). Several evidence-based screening tools can be used to help identify patients for severe sepsis. Chart 14-6 provides key elements of assessment and interventions that, when used together, may help identify patients with sepsis and guide early interventions in the treatment of severe sepsis and septic shock (IHI, 2012b; Surviving Sepsis Campaign, 2011).
Rapid identification of the infectious source is a critical element in managing sepsis. Specimens of blood, sputum, urine, wound drainage, and tips of invasive catheters are collected for culture using aseptic technique. IV lines are removed and reinserted at alternate sites. If possible, urinary catheters are removed or changed. Any abscesses are drained, and necrotic areas are débrided. All cultures should be obtained prior to antibiotic administration. Current guidelines suggest that antibiotics should be initiated within the first hour of treatment of a patient with sepsis (Surviving Sepsis Campaign, 2011).
Research efforts are focusing on better identification and early aggressive treatment of patients with sepsis, rapid and effective restoration of tissue perfusion, evaluation and treatment of the patient’s immune response, and treatment of dysregulation of the coagulation system that occurs with severe sepsis (Funk et al., 2009).
Fluid Replacement Therapy
Fluid replacement must be instituted to correct tissue hypoperfusion that results from the incompetent vasculature and the inflammatory response. Reestablishing tissue perfusion through aggressive fluid resuscitation is key to the management of severe sepsis and septic shock (Dellinger et al., 2013;Nee & Rivers, 2011). Fluid challenges of 1,000 mL of crystalloids or 300 to 500 mL of colloids over 30 minutes may be required to aggressively treat sepsis-induced tissue hypoperfusion. In addition to monitoring BP, CVP, and urine output, serum lactate levels are monitored to assess effectiveness of fluid resuscitation. See Chart 14-6 for a list of the treatment endpoints of fluid resuscitation.
Pharmacologic Therapy
If the infecting organism is unknown, broad-spectrum antibiotic agents are started until culture and sensitivity reports are received (Dellinger et al., 2013; IHI, 2012b), at which time the antibiotic agents may be changed to agents that are more specific to the infecting organism and less toxic to the patient.
The 2008 guidelines for management of severe sepsis and septic shock recommend the administration of recombinant human activated protein C (rhAPC; drotrecogin alfa [Xigris]) to patients with end-organ dysfunction and high risk of death (Dellinger et al., 2013). However, ongoing research has found that the medication did not positively impact the outcome of patients with severe sepsis, and it is no longer available for patient use (Eli Lilly and Company, 2011).
If fluid therapy alone does not effectively improve tissue perfusion, vasopressor agents, specifically norepinephrine or dopamine, may be initiated to achieve a MAP of 65 mmHg or higher. Inotropic agents may also be administered to provide pharmacologic support to the myocardium. Packed red blood cells may be ordered to support oxygen delivery and transport to the tissues. Neuromuscular blockade agents and sedation agents may be required to reduce metabolic demands and provide comfort to the patient. Deep vein thrombosis (DVT) prophylaxis with low-dose unfractionated heparin or low-molecular-weight heparin, in combination with mechanical prophylaxis (e.g., sequential compression devices [SCDs]) should be initiated, as well as medications for stress ulcer prophylaxis (e.g., H2 blocking agents, proton pump inhibitors).
Nutritional Therapy
Aggressive nutritional supplementation should be initiated within 24 to 48 hours of ICU admission to address the hypermetabolic state present with septic shock (Aikten, Williams, Harvey, et al., 2011). Malnutrition further impairs the patient’s resistance to infection. Enteral feedings are preferred to the parenteral route because of the increased risk of iatrogenic infection associated with IV catheters; however, enteral feedings may not be possible if decreased perfusion to the GI tract reduces peristalsis and impairs absorption.
Nursing Management
Nurses caring for patients in any setting must keep in mind the risks of sepsis and the high mortality rate associated with sepsis, severe sepsis, and septic shock. All invasive procedures must be carried out with aseptic technique after careful hand hygiene. In addition, IV lines, arterial and venous puncture sites, surgical incisions, traumatic wounds, and urinary catheters must be monitored for signs of infection. Nursing interventions to prevent infection, specifically VAP, as well as actions to prevent pressure ulcers need to be implemented in the care of all patients. Nurses should identify patients who are at particular risk for sepsis and septic shock (i.e., older adults and immunosuppressed patients and those with extensive trauma, burns, or diabetes), keeping in mind that these high-risk patients may not develop typical or classic signs of infection and sepsis. For example, confusion may be the first sign of infection and sepsis in older adult patients.
When caring for a patient with septic shock, the nurse collaborates with other members of the health care team to identify the site and source of sepsis and the specific organisms involved. The nurse often obtains appropriate specimens for culture and sensitivity. Chart 14-7 highlights nursing considerations believed to be instrumental in preventing and treating severe sepsis.
Elevated body temperature (hyperthermia) is common with sepsis and raises the patient’s metabolic rate and oxygen consumption. Fever is one of the body’s natural mechanisms for fighting infections. Therefore, elevated temperatures may not be treated unless they reach dangerous levels (more than 40°C [104°F]) or unless the patient is uncomfortable. Efforts may be made to reduce the temperature by administering acetaminophen or applying a hypothermia blanket. During these therapies, the nurse monitors the patient closely for shivering, which increases oxygen consumption. Efforts to increase comfort are important if the patient experiences fever, chills, or shivering.
The nurse administers prescribed IV fluids and medications, including antibiotic agents and vasoactive medications, to restore vascular volume. Because of decreased perfusion, serum concentrations of antibiotic agents that are normally cleared by the kidneys and liver may increase and produce toxic effects. Therefore, the nurse monitors blood levels (peak and trough levels of antibiotic agents, procalcitonin, CRP, BUN, creatinine, white blood cell count, hemoglobin, hematocrit, platelet levels, coagulation studies) and reports changes to the primary provider. As with other types of shock, the nurse monitors the patient’s hemodynamic status, fluid I&O, and nutritional status. Daily weights and close monitoring of serum albumin and prealbumin levels help determine the patient’s protein requirements.
49) Clotting/Disseminated intravascular coagulation (DIC)/Pathophysiology
Pathophysiology In DIC, normal hemostatic mechanisms are altered. The inflammatory response generated by the underlying disease initiates the process of inflammation and coagulation within the vasculature. The natural anticoagulant pathways within the body are simultaneously impaired, and the fibrinolytic system is suppressed so that a massive amount of tiny clots forms in the microcirculation. Initially, the coagulation time is normal. However, as the platelets and clotting factors form microthrombi, coagulation fails. Thus, the paradoxical result of excessive clotting is bleeding (Fig. 33-7). The clinical manifestations of DIC are primarily reflected in compromised organ function or failure. Decline in organ function is usually a result of excessive clot formation (with resultant ischemia to all or part of the organ) or, less often, of bleeding. The excessive clotting triggers the fibrinolytic system to release fibrin degradation products, which are potent anticoagulants, furthering the bleeding. The bleeding is characterized by low platelet and fibrinogen levels; prolonged PT, aPTT, and thrombin time; and elevated fibrin degradation products and D-dimers. The mortality rate can exceed 80% in patients who develop severe DIC with ischemic thrombosis, frank hemorrhage, and multiple organ dysfunction syndrome (MODS). Identification of patients who are at risk for DIC and recognition of the early clinical manifestations of this syndrome can result in prompt medical intervention, which may improve the prognosis. However, the primary prognostic factor is the ability to treat the underlying condition that precipitated DIC.
50) Perfusion/Myocardial Infarction/MI Core measure set
CHART 27-8
Acute Myocardial Infarction Core Measure Set
• Aspirin administered upon arrival to the hospital
• Aspirin prescribed at discharge from the hospital
• ACE inhibitor or ARB prescribed for patients with concomitant left ventricular systolic dysfunction
• Adult smoking cessation advice/counseling as needed
• Beta-blocker prescribed at discharge from the hospital
• Thrombolytic (fibrinolytic) therapy received within 30 minutes of hospital arrival
• PCI received within 90 minutes of hospital arrival
• Statin prescribed at discharge
A patient with cardiovascular disease is being treated with amlodipine (Norvasc), a calcium channel blocking agent. The therapeutic effects of calcium channel blockers include which of the following?
A)Reducing the heart's workload by decreasing heart rate and myocardial Contraction
B)Preventing platelet aggregation and subsequent thrombosis
C)Reducing myocardial oxygen consumption by blocking adrenergic stimulation to the heart
D)Increasing the efficiency of myocardial oxygen consumption, thus decreasing
ischemia and relieving pain
Ans:A
Calcium channel blocking agents decrease sinoatrial node automaticity and
atrioventricular node conduction, resulting in a slower heart rate and a decrease in the
strength of the heart muscle contraction. These effects decrease the workload of the
heart. Antiplatelet and anticoagulation medications are administered to prevent platelet
aggregation and subsequent thrombosis, which impedes blood flow. Beta-blockers reduce myocardial consumption by blocking beta-adrenergic sympathetic stimulation to the heart. The result is reduced myocardial contractility (force of contraction) to balance the myocardium oxygen needs and supply. Nitrates reduce myocardial oxygen consumption, which decreases ischemia and relieves pain by dilating the veins and, in higher doses, the arteries.
The nurse is caring for a patient who is believed to have just experienced an MI. The nurse notes changes in the ECG of the patient. What change on an ECG most strongly suggests to the nurse that ischemia is occurring?
A)P wave inversion
B)T wave inversion
C)Q wave changes with no change in ST or T wave
D)P wave enlargement
Ans:B
Feedback:T-wave inversion is an indicator of ischemic damage to myocardium.
A patient presents to the ED in distress and complaining of “crushing” chest pain. What
is the nurse's priority for assessment?
A)Prompt initiation of an ECG
B)Auscultation of the patient's point of maximal impulse (PMI)
C)Rapid assessment of the patient's peripheral pulses
D)Palpation of the patient's cardiac apex
Ans:A
Feedback:The 12-lead ECG provides information that assists in ruling out or diagnosing an acute MI.
The ED nurse is caring for a patient with a suspected MI. What drug should the nurse
anticipate administering to this patient?
A)Oxycodone
B)Warfarin
C)Morphine
D)Acetaminophen
Ans:C
[Show More]